| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate phosphatase activity | 3.86e-05 | 30 | 259 | 5 | GO:0052866 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATRX CENPE ABCA13 IFIH1 NAE1 ATP11C DDX24 DDX4 ACSS3 ATP13A4 MYO1H KIF20B MMAA ORC1 KIF4B MORC3 MTREX ATP1A3 POLQ SNRNP200 | 1.60e-04 | 614 | 259 | 20 | GO:0140657 |
| GeneOntologyMolecularFunction | Rab GDP-dissociation inhibitor activity | 1.68e-04 | 2 | 259 | 2 | GO:0005093 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | CADM3 DCHS2 CLSTN3 CD164 WNK1 KIRREL3 FAT1 HMCN2 NRXN1 PTPRS CNTN5 PVR NECTIN2 SDK1 ICAM1 PCDH11Y CELSR2 HMCN1 | 8.16e-08 | 313 | 256 | 18 | GO:0098742 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | CADM3 DCHS2 CLSTN3 KIRREL3 FAT1 HMCN2 CNTN5 PVR NECTIN2 SDK1 PCDH11Y CELSR2 HMCN1 | 6.47e-07 | 187 | 256 | 13 | GO:0007156 |
| GeneOntologyBiologicalProcess | mitotic cell cycle checkpoint signaling | 3.80e-05 | 163 | 256 | 10 | GO:0007093 | |
| GeneOntologyCellularComponent | IgG immunoglobulin complex | 2.00e-05 | 14 | 256 | 4 | GO:0071735 | |
| GeneOntologyCellularComponent | IgD immunoglobulin complex | 3.53e-05 | 6 | 256 | 3 | GO:0071738 | |
| GeneOntologyCellularComponent | IgE immunoglobulin complex | 3.53e-05 | 6 | 256 | 3 | GO:0071742 | |
| GeneOntologyCellularComponent | pi-body | 2.79e-04 | 11 | 256 | 3 | GO:0071546 | |
| Domain | Ig_I-set | CADM3 TRIO SPEG VSIG4 OBSCN IGSF10 KIRREL3 HMCN2 CEACAM21 PTPRS CNTN5 SDK1 ADAMTSL1 HMCN1 MYBPC2 | 3.85e-08 | 190 | 248 | 15 | IPR013098 |
| Domain | I-set | CADM3 TRIO SPEG VSIG4 OBSCN IGSF10 KIRREL3 HMCN2 CEACAM21 PTPRS CNTN5 SDK1 ADAMTSL1 HMCN1 MYBPC2 | 3.85e-08 | 190 | 248 | 15 | PF07679 |
| Domain | IGc2 | CADM3 TRIO SPEG VSIG4 OBSCN IGSF10 KIRREL3 HMCN2 CEACAM21 PTPRS CNTN5 SDK1 ADAMTSL1 HMCN1 FCRL5 MYBPC2 | 1.07e-07 | 235 | 248 | 16 | SM00408 |
| Domain | Ig_sub2 | CADM3 TRIO SPEG VSIG4 OBSCN IGSF10 KIRREL3 HMCN2 CEACAM21 PTPRS CNTN5 SDK1 ADAMTSL1 HMCN1 FCRL5 MYBPC2 | 1.07e-07 | 235 | 248 | 16 | IPR003598 |
| Domain | IG | CADM3 TRIO SPEG VSIG4 OBSCN IGSF10 KIRREL3 HMCN2 CEACAM21 BTNL3 PTPRS CNTN5 PVR NECTIN2 SDK1 ADAMTSL1 ICAM1 HMCN1 CD80 FCRL5 MYBPC2 | 2.27e-07 | 421 | 248 | 21 | SM00409 |
| Domain | Ig_sub | CADM3 TRIO SPEG VSIG4 OBSCN IGSF10 KIRREL3 HMCN2 CEACAM21 BTNL3 PTPRS CNTN5 PVR NECTIN2 SDK1 ADAMTSL1 ICAM1 HMCN1 CD80 FCRL5 MYBPC2 | 2.27e-07 | 421 | 248 | 21 | IPR003599 |
| Domain | IG_LIKE | CADM3 TRIO SPEG VSIG4 OBSCN IGSF10 KIRREL3 HMCN2 CEACAM21 BTNL3 PTPRS CNTN5 PVR NECTIN2 SDK1 ADAMTSL1 ICAM1 HMCN1 CD80 IGLC3 FCRL5 MYBPC2 | 7.17e-07 | 491 | 248 | 22 | PS50835 |
| Domain | Ig-like_fold | CADM3 TRIO SPEG VSIG4 OBSCN IGSF10 KIRREL3 HMCN2 CEACAM21 BTNL3 PTPRS CNTN5 PVR NECTIN2 COL14A1 SDK1 PLXNA2 ADAMTSL1 ICAM1 PKHD1L1 HMCN1 CD80 IGLC3 FCRL5 EPHA10 EPHA5 MYBPC2 | 8.50e-07 | 706 | 248 | 27 | IPR013783 |
| Domain | Ig-like_dom | CADM3 TRIO SPEG VSIG4 OBSCN IGSF10 KIRREL3 HMCN2 CEACAM21 BTNL3 PTPRS CNTN5 PVR NECTIN2 SDK1 ADAMTSL1 ICAM1 HMCN1 CD80 IGLC3 FCRL5 MYBPC2 | 1.07e-06 | 503 | 248 | 22 | IPR007110 |
| Domain | HECT | 1.21e-06 | 27 | 248 | 6 | PF00632 | |
| Domain | HECTc | 1.21e-06 | 27 | 248 | 6 | SM00119 | |
| Domain | HECT_dom | 1.21e-06 | 27 | 248 | 6 | IPR000569 | |
| Domain | HECT | 1.21e-06 | 27 | 248 | 6 | PS50237 | |
| Domain | - | CADM3 TRIO SPEG VSIG4 OBSCN IGSF10 KIRREL3 CEACAM21 BTNL3 PTPRS CNTN5 PVR NECTIN2 COL14A1 SDK1 PLXNA2 ADAMTSL1 ICAM1 PKHD1L1 HMCN1 CD80 FCRL5 EPHA10 EPHA5 MYBPC2 | 2.85e-06 | 663 | 248 | 25 | 2.60.40.10 |
| Domain | RCC1 | 5.22e-06 | 20 | 248 | 5 | PF00415 | |
| Domain | RCC1_1 | 6.78e-06 | 21 | 248 | 5 | PS00625 | |
| Domain | RCC1_2 | 6.78e-06 | 21 | 248 | 5 | PS00626 | |
| Domain | RCC1_3 | 6.78e-06 | 21 | 248 | 5 | PS50012 | |
| Domain | - | 8.68e-06 | 22 | 248 | 5 | 2.130.10.30 | |
| Domain | Reg_chr_condens | 8.68e-06 | 22 | 248 | 5 | IPR000408 | |
| Domain | RCC1/BLIP-II | 1.10e-05 | 23 | 248 | 5 | IPR009091 | |
| Domain | IGv | 6.16e-05 | 75 | 248 | 7 | SM00406 | |
| Domain | Ig_V-set | CADM3 VSIG4 OBSCN IGSF10 KIRREL3 CEACAM21 BTNL3 PVR NECTIN2 HMCN1 CD80 | 7.42e-05 | 199 | 248 | 11 | IPR013106 |
| Domain | RabGDI | 1.76e-04 | 2 | 248 | 2 | IPR000806 | |
| Domain | PH_dom-like | TRIO OBSCN PLEKHH3 SPTBN5 SHC2 MTMR3 MTMR2 ARAP1 ARHGEF25 SH2D5 TIAM1 RANBP3L SBF2 WDFY3 LRBA FRMD3 | 1.94e-04 | 426 | 248 | 16 | IPR011993 |
| Domain | C2-set_2 | 2.01e-04 | 41 | 248 | 5 | PF08205 | |
| Domain | CD80_C2-set | 2.01e-04 | 41 | 248 | 5 | IPR013162 | |
| Domain | - | 2.74e-04 | 95 | 248 | 7 | 2.60.120.200 | |
| Domain | fn3 | 3.22e-04 | 162 | 248 | 9 | PF00041 | |
| Domain | BAH | 3.53e-04 | 11 | 248 | 3 | PS51038 | |
| Domain | BAH_dom | 3.53e-04 | 11 | 248 | 3 | IPR001025 | |
| Domain | BAH | 3.53e-04 | 11 | 248 | 3 | SM00439 | |
| Domain | BAH | 3.53e-04 | 11 | 248 | 3 | PF01426 | |
| Domain | ASX_HYDROXYL | 3.75e-04 | 100 | 248 | 7 | PS00010 | |
| Domain | UCP038083_PDZ | 5.22e-04 | 3 | 248 | 2 | IPR017379 | |
| Domain | CLCA_chordata | 5.22e-04 | 3 | 248 | 2 | IPR004727 | |
| Domain | CLCA | 5.22e-04 | 3 | 248 | 2 | IPR013642 | |
| Domain | CLCA | 5.22e-04 | 3 | 248 | 2 | PF08434 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 5.34e-04 | 106 | 248 | 7 | IPR000152 | |
| Domain | - | DCAF12L2 BIRC6 CIAO1 PLXNA2 WDFY1 WDR5B WDR27 WDR5 PREB DCAF12L1 CSTF1 WDFY3 LRBA | 5.37e-04 | 333 | 248 | 13 | 2.130.10.10 |
| Domain | Helicase_C | 5.65e-04 | 107 | 248 | 7 | PF00271 | |
| Domain | HELICc | 5.65e-04 | 107 | 248 | 7 | SM00490 | |
| Domain | WD40/YVTN_repeat-like_dom | DCAF12L2 BIRC6 CIAO1 PLXNA2 WDFY1 WDR5B WDR27 WDR5 PREB DCAF12L1 CSTF1 WDFY3 LRBA | 5.68e-04 | 335 | 248 | 13 | IPR015943 |
| Domain | Helicase_C | 5.97e-04 | 108 | 248 | 7 | IPR001650 | |
| Domain | DEXDc | 6.31e-04 | 109 | 248 | 7 | SM00487 | |
| Domain | HELICASE_CTER | 6.31e-04 | 109 | 248 | 7 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 6.31e-04 | 109 | 248 | 7 | PS51192 | |
| Domain | Helicase_ATP-bd | 6.67e-04 | 110 | 248 | 7 | IPR014001 | |
| Domain | ConA-like_dom | CLSTN3 RYR2 FAT1 NRXN1 BTNL3 COL14A1 CELSR2 PAPPA WDFY3 LRBA | 7.17e-04 | 219 | 248 | 10 | IPR013320 |
| Domain | WD40 | DCAF12L2 CIAO1 WDFY1 WDR5B WDR27 WDR5 PREB DCAF12L1 CSTF1 WDFY3 LRBA | 7.18e-04 | 259 | 248 | 11 | PF00400 |
| Domain | PPASE_MYOTUBULARIN | 7.56e-04 | 14 | 248 | 3 | PS51339 | |
| Domain | Myotubularin-like_Pase_dom | 7.56e-04 | 14 | 248 | 3 | IPR010569 | |
| Domain | Myotubularin_fam | 7.56e-04 | 14 | 248 | 3 | IPR030564 | |
| Domain | Myotub-related | 7.56e-04 | 14 | 248 | 3 | PF06602 | |
| Domain | EGF-like_CS | ADGRE2 BMP1 FAT1 HMCN2 NRXN1 PLAU CELSR2 HMCN1 MUC3A EPHA10 EPHA5 | 7.65e-04 | 261 | 248 | 11 | IPR013032 |
| Domain | - | TRIO OBSCN PLEKHH3 SPTBN5 SHC2 MTMR3 MTMR2 ARAP1 ARHGEF25 SH2D5 TIAM1 RANBP3L SBF2 FRMD3 | 7.76e-04 | 391 | 248 | 14 | 2.30.29.30 |
| Domain | VWFA | 7.78e-04 | 82 | 248 | 6 | PS50234 | |
| Domain | FN3 | 8.41e-04 | 185 | 248 | 9 | SM00060 | |
| Domain | EGF_2 | ADGRE2 BMP1 FAT1 HMCN2 NRXN1 PLAU CELSR2 HMCN1 MUC3A EPHA10 EPHA5 | 8.66e-04 | 265 | 248 | 11 | PS01186 |
| Domain | VWA | 8.84e-04 | 84 | 248 | 6 | SM00327 | |
| Domain | WD40 | DCAF12L2 CIAO1 WDFY1 WDR5B WDR27 WDR5 PREB DCAF12L1 CSTF1 WDFY3 LRBA | 9.49e-04 | 268 | 248 | 11 | SM00320 |
| Domain | ig | 1.02e-03 | 190 | 248 | 9 | PF00047 | |
| Domain | Immunoglobulin | 1.02e-03 | 190 | 248 | 9 | IPR013151 | |
| Domain | NIDOGEN_G2 | 1.04e-03 | 4 | 248 | 2 | PS50993 | |
| Domain | GDP_dissociation_inhibitor | 1.04e-03 | 4 | 248 | 2 | IPR018203 | |
| Domain | G2_nidogen/fibulin_G2F | 1.04e-03 | 4 | 248 | 2 | IPR006605 | |
| Domain | G2F | 1.04e-03 | 4 | 248 | 2 | PF07474 | |
| Domain | GDI | 1.04e-03 | 4 | 248 | 2 | PF00996 | |
| Domain | GFP | 1.04e-03 | 4 | 248 | 2 | IPR009017 | |
| Domain | WD40_repeat | DCAF12L2 CIAO1 WDFY1 WDR5B WDR27 WDR5 PREB DCAF12L1 CSTF1 WDFY3 LRBA | 1.07e-03 | 272 | 248 | 11 | IPR001680 |
| Domain | WD_REPEATS_1 | DCAF12L2 CIAO1 WDFY1 WDR5B WDR27 WDR5 PREB DCAF12L1 CSTF1 WDFY3 LRBA | 1.28e-03 | 278 | 248 | 11 | PS00678 |
| Domain | WD_REPEATS_2 | DCAF12L2 CIAO1 WDFY1 WDR5B WDR27 WDR5 PREB DCAF12L1 CSTF1 WDFY3 LRBA | 1.31e-03 | 279 | 248 | 11 | PS50082 |
| Domain | WD_REPEATS_REGION | DCAF12L2 CIAO1 WDFY1 WDR5B WDR27 WDR5 PREB DCAF12L1 CSTF1 WDFY3 LRBA | 1.31e-03 | 279 | 248 | 11 | PS50294 |
| Domain | FN3 | 1.40e-03 | 199 | 248 | 9 | PS50853 | |
| Domain | C2_dom | 1.59e-03 | 164 | 248 | 8 | IPR000008 | |
| Domain | Pyr_OxRdtase_I_AS | 1.71e-03 | 5 | 248 | 2 | IPR012999 | |
| Domain | Pyr_redox_dim | 1.71e-03 | 5 | 248 | 2 | PF02852 | |
| Domain | DUF4704 | 1.71e-03 | 5 | 248 | 2 | IPR031570 | |
| Domain | DUF4704 | 1.71e-03 | 5 | 248 | 2 | PF15787 | |
| Domain | Autophagy-rel_C | 1.71e-03 | 5 | 248 | 2 | IPR015412 | |
| Domain | PYRIDINE_REDOX_1 | 1.71e-03 | 5 | 248 | 2 | PS00076 | |
| Domain | ATG_C | 1.71e-03 | 5 | 248 | 2 | PF09333 | |
| Domain | EGF-like_dom | 1.88e-03 | 249 | 248 | 10 | IPR000742 | |
| Domain | FN3_dom | 1.96e-03 | 209 | 248 | 9 | IPR003961 | |
| Domain | VWF_A | 2.07e-03 | 99 | 248 | 6 | IPR002035 | |
| Domain | WD40_repeat_dom | DCAF12L2 CIAO1 WDFY1 WDR5B WDR27 WDR5 PREB DCAF12L1 CSTF1 WDFY3 LRBA | 2.15e-03 | 297 | 248 | 11 | IPR017986 |
| Domain | EFG_C | 2.54e-03 | 6 | 248 | 2 | PF00679 | |
| Domain | PH_BEACH | 2.54e-03 | 6 | 248 | 2 | PF14844 | |
| Domain | EFG_C | 2.54e-03 | 6 | 248 | 2 | SM00838 | |
| Domain | EFG_III-V | 2.54e-03 | 6 | 248 | 2 | IPR009022 | |
| Domain | DEAD/DEAH_box_helicase_dom | 2.86e-03 | 73 | 248 | 5 | IPR011545 | |
| Domain | DEAD | 2.86e-03 | 73 | 248 | 5 | PF00270 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | 6.83e-06 | 53 | 191 | 7 | M662 | |
| Pathway | REACTOME_PI_METABOLISM | 1.77e-05 | 84 | 191 | 8 | M676 | |
| Pathway | REACTOME_PI_METABOLISM | 8.11e-05 | 77 | 191 | 7 | MM14590 | |
| Pathway | REACTOME_NECTIN_NECL_TRANS_HETERODIMERIZATION | 8.23e-05 | 7 | 191 | 3 | M27333 | |
| Pathway | REACTOME_NECTIN_NECL_TRANS_HETERODIMERIZATION | 8.23e-05 | 7 | 191 | 3 | MM15068 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ATRX TRIO ASH1L OBSCN YJEFN3 PPM1H TASOR2 ZNF462 TTC8 TNRC18 SHC2 SYNJ2 PTPRS PVR NECTIN2 ARID5B RIPOR1 ANKRD12 SMURF2 ARAP1 CARMIL1 PCDH11Y SMURF1 WDR27 CEP192 AHCYL2 TECTA GTF2IRD1 AR THADA PCNX4 GCC2 PKP3 CBFA2T2 SBF2 SCAF11 LRBA PCCA ICA1L FRMD3 | 2.15e-12 | 1489 | 259 | 40 | 28611215 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SETD1A TRIO SPEG OBSCN NBL1 ATG2A WNK1 BIRC6 PLEKHH3 FAT1 TNRC18 PTPRS MTMR3 RIPOR1 SMURF2 ARAP1 CEP192 TXNRD2 MED13L GTF2IRD1 NR2F2 ORC1 THADA CELSR2 PLA2G4B PCNX4 SBF2 PAXIP1 DEPDC5 PRKDC WDFY3 LRBA ESPL1 | 1.43e-11 | 1105 | 259 | 33 | 35748872 |
| Pubmed | CLSTN3 SPEG ZNF423 KIRREL3 MTMR3 RIPOR1 HERC3 ANKRD12 PLXNA2 SMURF1 HEATR5A CEP192 AHCYL2 MED13L GCC2 SIPA1L1 ZMYM3 | 1.38e-08 | 407 | 259 | 17 | 12693553 | |
| Pubmed | SETD1A ATRX SENP3 BIRC6 TASOR2 ZNF462 NUP98 REST PPP2R1A IBTK CTNNBL1 INTS4 SMARCC2 SCAF11 EIF3F MORC3 PCNA | 1.07e-07 | 469 | 259 | 17 | 27634302 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | ATRX ADAR ZNF462 ARID5B RTCB WDR5 AR RBM12 PRKDC MORC3 MTREX SNRNP200 | 1.13e-07 | 220 | 259 | 12 | 35785414 |
| Pubmed | DCHS2 CLSTN3 ATRX TRIO ZNF423 ASH1L GDI1 GUF1 GLS ARID5B MTMR3 MTMR2 SMURF2 ACTR8 ADAMTS8 MED13L CPNE5 FAN1 TIAM1 SIPA1L1 ASB3 PRKDC EIF3F WDFY3 LRBA MORC3 USPL1 ZNF439 SNRNP200 | 1.30e-07 | 1285 | 259 | 29 | 35914814 | |
| Pubmed | WNK1 BIRC6 ZNF462 NRXN1 ARAP1 ANGPT1 ALPK1 MED13L RBM12 SIPA1L1 WDFY3 SNRNP200 | 1.45e-07 | 225 | 259 | 12 | 12168954 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | CENPE MRPL43 GDI2 TASOR2 SERPINB5 SYNJ2 BUB1 DKC1 ARAP1 CARMIL1 ICAM1 NUP98 WDR5 CEP192 PREB ORC1 PPP2R1A CTNNBL1 SMARCC2 KIF4B PRKDC EIF3F MORC3 ESPL1 SNRNP200 ZMYM3 PCNA | 1.83e-07 | 1155 | 259 | 27 | 20360068 |
| Pubmed | 2.05e-07 | 8 | 259 | 4 | 3122211 | ||
| Pubmed | 2.05e-07 | 8 | 259 | 4 | 27034402 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | SETD1A ATRX SENP3 DKC1 APOBEC3C DDX24 ACTR8 RTCB WDR5 PPP2R1A SMARCC2 SCAF11 PRKDC ZMYM3 PCNA | 3.27e-07 | 394 | 259 | 15 | 27248496 |
| Pubmed | Clustered arrangement of immunoglobulin lambda constant region genes in man. | 3.68e-07 | 9 | 259 | 4 | 6273747 | |
| Pubmed | 4.08e-07 | 3 | 259 | 3 | 12077254 | ||
| Pubmed | 4.08e-07 | 3 | 259 | 3 | 2515285 | ||
| Pubmed | CADM3 TRIO SPEG OBSCN IGSF10 KIRREL3 PTPRS CNTN5 NECTIN2 HMCN1 | 4.23e-07 | 162 | 259 | 10 | 25826454 | |
| Pubmed | SENP3 CBARP BIRC6 RYR2 TASOR2 FAT1 NECTIN2 VPS13A TACC1 SDK1 ACBD5 NUP98 CEP192 PKHD1L1 THADA GCC2 PRKDC LRBA PCCA SNRNP200 PCNA | 4.59e-07 | 777 | 259 | 21 | 35844135 | |
| Pubmed | NRXN1 PTPRS OSGEPL1 DKC1 HERC6 CLCA4 ANGPT1 CARMIL1 NUP98 IBTK HERC4 | 8.34e-07 | 218 | 259 | 11 | 19460752 | |
| Pubmed | A global genomic transcriptional code associated with CNS-expressed genes. | ZBTB6 SPEG MRPL43 ZNF462 NRXN1 CRYZL1 CARMIL1 NR2F2 PPP1R3A MMAA INSIG2 LRBA PCCA | 9.15e-07 | 318 | 259 | 13 | 16919269 |
| Pubmed | System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes. | 1.28e-06 | 26 | 259 | 5 | 26949039 | |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | ADAR DKC1 TACC1 HERC3 RTCB ACBD5 REST GTF2IRD1 DENND4C SIPA1L1 SBF2 | 1.53e-06 | 232 | 259 | 11 | 25515538 |
| Pubmed | 1.62e-06 | 4 | 259 | 3 | 4415202 | ||
| Pubmed | 1.62e-06 | 4 | 259 | 3 | 4215080 | ||
| Pubmed | Immunoglobulin lambda-chains. The complete amino acid sequence of a Bence-Jones protein. | 1.62e-06 | 4 | 259 | 3 | 4883841 | |
| Pubmed | 1.62e-06 | 4 | 259 | 3 | 29051491 | ||
| Pubmed | 1.62e-06 | 4 | 259 | 3 | 6404900 | ||
| Pubmed | 1.62e-06 | 4 | 259 | 3 | 5549568 | ||
| Pubmed | SENP3 DCAF12L2 GDI1 RYR2 SERPINB5 GLS VPS13A ARID5B HERC6 ANKRD52 ACSS3 ATP13A4 HUS1 ZDBF2 GCC2 PAXIP1 SMARCC2 WDFY3 | 1.71e-06 | 638 | 259 | 18 | 31182584 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | ATRX CENPE WNK1 BRCA2 PLA2G12A CIAO1 BUB1 ARID5B ANKRD52 ZDBF2 CEP192 KIF20B GSR PPP2R1A MORC3 MTREX ZMYM3 | 2.41e-06 | 588 | 259 | 17 | 38580884 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | CENPE MRPL43 BIRC6 GDI2 FANCD2 SPTBN5 GUF1 ERAL1 GLS BUB1 VPS13A SLMAP MTMR3 DKC1 TACC1 NME3 DDX24 DDX4 ACAD9 ACBD5 NUP98 ZDBF2 AHCYL2 GFM2 DARS2 PREB IBTK THADA ESPL1 | 2.80e-06 | 1496 | 259 | 29 | 32877691 |
| Pubmed | BIRC6 ZNF462 BRCA2 GLS BUB1 ARID5B ANKRD52 ZDBF2 KIF20B DENND4C GCC2 LRBA PCCA ZMYM3 | 3.61e-06 | 418 | 259 | 14 | 34709266 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SETD1A SENP3 ADAR BIRC6 GUF1 ERAL1 CIAO1 GLS DKC1 APOBEC3C DDX24 ANKRD52 RTCB WDR5 KIF20B ORC1 PPP2R1A CTNNBL1 CSTF1 SMARCC2 PRKDC EIF3F WDFY3 MTREX SNRNP200 ZMYM3 PCNA | 3.72e-06 | 1353 | 259 | 27 | 29467282 |
| Pubmed | 3.85e-06 | 15 | 259 | 4 | 20176268 | ||
| Pubmed | 4.04e-06 | 5 | 259 | 3 | 19704162 | ||
| Pubmed | Amino acid sequence of the (lambda) light chain of a human myeloma immunoglobulin (IgG New). | 4.04e-06 | 5 | 259 | 3 | 4814727 | |
| Pubmed | 4.04e-06 | 5 | 259 | 3 | 4909564 | ||
| Pubmed | 4.04e-06 | 5 | 259 | 3 | 15676274 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | ATRX WNK1 GDI1 PPM1H TTC8 NRXN1 NECTIN2 BUB1 COL14A1 RIPOR1 DDX24 RTCB ACAD9 CARMIL1 WDR5 DENND4C DARS2 DNAAF2 PPP2R1A THADA TIAM1 GCC2 SIPA1L1 MORC3 MUC5AC SNRNP200 | 7.25e-06 | 1321 | 259 | 26 | 27173435 |
| Pubmed | WNK1 BIRC6 PPM1H SLMAP MTMR3 ANKRD52 WWC1 PARP8 CEP192 DENND4C PPP2R1A SIPA1L1 PRKDC MTREX | 7.55e-06 | 446 | 259 | 14 | 24255178 | |
| Pubmed | PtdIns5P regulation through evolution: roles in membrane trafficking? | 8.03e-06 | 6 | 259 | 3 | 18774718 | |
| Pubmed | 8.03e-06 | 6 | 259 | 3 | 19730684 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | ATRX SPEG DKC1 FGG SASH1 SH2D5 PPP2R1A TIAM1 SIPA1L1 SMARCC2 | 1.02e-05 | 231 | 259 | 10 | 16452087 |
| Pubmed | 1.11e-05 | 101 | 259 | 7 | 10997877 | ||
| Pubmed | 1.40e-05 | 7 | 259 | 3 | 18535780 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ATRX SENP3 NR4A1 ADAR ARID5B DKC1 DDX24 ACTR8 RTCB NUP98 WDR5 REST GTF2IRD1 PREB ORC1 PPP2R1A PKP3 PAXIP1 INTS4 SCAF11 PRKDC MTREX PCCA SNRNP200 ZMYM3 | 1.50e-05 | 1294 | 259 | 25 | 30804502 |
| Pubmed | 1.71e-05 | 195 | 259 | 9 | 19454010 | ||
| Pubmed | Characterization of the two unique human anti-flavin monoclonal immunoglobulins. | 2.22e-05 | 8 | 259 | 3 | 7737190 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ATRX FANCD2 DKC1 RIPOR1 DDX24 CARMIL1 NUP98 REST GTF2IRD1 PKP3 CBFA2T2 SIPA1L1 SMARCC2 SCAF11 PRKDC ESPL1 SNRNP200 ZMYM3 | 2.35e-05 | 774 | 259 | 18 | 15302935 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | SETD1A TPTE INPP5D MRPL43 ATG2A WNK1 TASOR2 TNRC18 PIK3R2 BUB1 ARAP1 NUP98 CBFA2T2 | 2.37e-05 | 430 | 259 | 13 | 35044719 |
| Pubmed | ADCY10 MRPL43 ADAR GDI1 GDI2 FANCD2 HMCN2 ERAL1 NAE1 MTMR3 DKC1 DDX24 WDR5B RTCB ACAD9 WDR5 DARS2 PPP2R1A CTNNBL1 SMARCC2 PRKDC EIF3F MTREX SNRNP200 PCNA | 2.51e-05 | 1335 | 259 | 25 | 29229926 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | TRIO CENPE ATG2A GDI2 CCDC66 BRCA2 SYNJ2 MTMR2 DKC1 ANKRD52 HUS1 CARMIL1 CEP192 IBTK MEIOC SIPA1L1 MORC3 PCCA PCNA | 2.51e-05 | 853 | 259 | 19 | 28718761 |
| Pubmed | ATRX ADAR GDI2 FANCD2 SERPINB5 NAE1 DKC1 AK1 NUP98 WDR5 MED13L NR2F2 PPP2R1A RBM12 CTNNBL1 CSTF1 SMARCC2 PRKDC EIF3F MTREX PCNA | 2.74e-05 | 1014 | 259 | 21 | 32416067 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 3.31e-05 | 212 | 259 | 9 | 33853758 | |
| Pubmed | 3.32e-05 | 9 | 259 | 3 | 10335479 | ||
| Pubmed | Structure and expression of the human immunoglobulin lambda genes. | 3.32e-05 | 9 | 259 | 3 | 2115572 | |
| Pubmed | PIDD orchestrates translesion DNA synthesis in response to UV irradiation. | 3.36e-05 | 25 | 259 | 4 | 21415862 | |
| Pubmed | A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers. | 4.42e-05 | 125 | 259 | 7 | 21654808 | |
| Pubmed | TPTE TRIO CBARP BIRC6 PPM1H FANCD2 PTPRS NECTIN2 VPS13A MTMR3 MTMR2 ANKRD52 ACBD5 NUP98 CEP192 PPEF1 FAN1 PPP2R1A TIAM1 SBF2 INTS4 | 4.46e-05 | 1049 | 259 | 21 | 27880917 | |
| Pubmed | Characterization of the myotubularin dual specificity phosphatase gene family from yeast to human. | 4.71e-05 | 10 | 259 | 3 | 9736772 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | TPTE FANCD2 PTPRS ERAL1 CIAO1 MTMR3 MTMR2 ANKRD52 WWC1 RTCB ACAD9 NUP98 PPEF1 GSR PPP2R1A PKP3 CSTF1 PRKDC ESPL1 SNRNP200 | 4.80e-05 | 974 | 259 | 20 | 28675297 |
| Pubmed | Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. | 4.91e-05 | 87 | 259 | 6 | 17148452 | |
| Pubmed | Substrate trapping proteomics reveals targets of the βTrCP2/FBXW11 ubiquitin ligase. | 5.15e-05 | 128 | 259 | 7 | 25332235 | |
| Pubmed | ATRX MRPL43 CBARP GUF1 ERAL1 GLG1 PIK3R2 NAE1 GLS NECTIN2 VPS13A SLMAP COL14A1 TACC1 DDX24 ANKRD52 ACAD9 ACBD5 CEP192 DARS2 GSR PREB THADA TIAM1 ESPL1 SNRNP200 | 5.40e-05 | 1487 | 259 | 26 | 33957083 | |
| Pubmed | ADAR-mediated RNA editing regulates PVR immune checkpoint in colorectal cancer. | 5.52e-05 | 2 | 259 | 2 | 38176170 | |
| Pubmed | Targeting an Achilles' heel of cancer with a WRN helicase inhibitor. | 5.52e-05 | 2 | 259 | 2 | 24036544 | |
| Pubmed | Effect of luteolin on gene expression in mouse H22 hepatoma cells. | 5.52e-05 | 2 | 259 | 2 | 26600503 | |
| Pubmed | Increased CD112 expression in methylcholanthrene-induced tumors in CD155-deficient mice. | 5.52e-05 | 2 | 259 | 2 | 25384044 | |
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 18848472 | ||
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 16936271 | ||
| Pubmed | ADAR1 RNA editing regulates endothelial cell functions via the MDA-5 RNA sensing signaling pathway. | 5.52e-05 | 2 | 259 | 2 | 34969816 | |
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 21921234 | ||
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 37421629 | ||
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 33982774 | ||
| Pubmed | The CMT4B disease-causing proteins MTMR2 and MTMR13/SBF2 regulate AKT signalling. | 5.52e-05 | 2 | 259 | 2 | 19912440 | |
| Pubmed | Loss of SPEG Inhibitory Phosphorylation of Ryanodine Receptor Type-2 Promotes Atrial Fibrillation. | 5.52e-05 | 2 | 259 | 2 | 32683896 | |
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 11751384 | ||
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 38935501 | ||
| Pubmed | Ubiquitinated Fancd2 recruits Fan1 to stalled replication forks to prevent genome instability. | 5.52e-05 | 2 | 259 | 2 | 26797144 | |
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 7585614 | ||
| Pubmed | BRCA/Fanconi anemia pathway implicates chemoresistance to gemcitabine in biliary tract cancer. | 5.52e-05 | 2 | 259 | 2 | 25736055 | |
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 15983204 | ||
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 15185077 | ||
| Pubmed | Cardiac valve involvement in ADAR-related type I interferonopathy. | 5.52e-05 | 2 | 259 | 2 | 31772029 | |
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 17230527 | ||
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 20603016 | ||
| Pubmed | Microcell mediated chromosome transfer maps the Fanconi anaemia group D gene to chromosome 3p. | 5.52e-05 | 2 | 259 | 2 | 7581463 | |
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 12829919 | ||
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 17038506 | ||
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 11936473 | ||
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 16135554 | ||
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 24094106 | ||
| Pubmed | PTIP/Swift is required for efficient PCNA ubiquitination in response to DNA damage. | 5.52e-05 | 2 | 259 | 2 | 18353733 | |
| Pubmed | Survival of BRCA2-Deficient Cells Is Promoted by GIPC3, a Novel Genetic Interactor of BRCA2. | 5.52e-05 | 2 | 259 | 2 | 29021281 | |
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 31899247 | ||
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 15998640 | ||
| Pubmed | RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself. | 5.52e-05 | 2 | 259 | 2 | 26275108 | |
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 17898070 | ||
| Pubmed | Alternative transcription initiation and splicing variants of the DHRS4 gene cluster. | 5.52e-05 | 2 | 259 | 2 | 18754758 | |
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 16465045 | ||
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 18270197 | ||
| Pubmed | 5.52e-05 | 2 | 259 | 2 | 33090007 | ||
| Interaction | MRE11 interactions | ATRX SENP3 ADAR FANCD2 BMP1 CIAO1 AK1 RTCB NLRP2 AR GCC2 PAXIP1 SMARCC2 PRKDC POLQ | 4.13e-06 | 287 | 255 | 15 | int:MRE11 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | TRIO SPEG OBSCN IGSF10 KIRREL3 HMCN2 PTPRS CNTN5 SDK1 ADAMTSL1 HMCN1 MYBPC2 | 1.53e-07 | 161 | 192 | 12 | 593 |
| GeneFamily | X-linked mental retardation|RNA helicases | 3.84e-06 | 11 | 192 | 4 | 1168 | |
| GeneFamily | Immunoglobulin like domain containing | CADM3 VSIG4 KIRREL3 HMCN2 CEACAM21 CNTN5 PVR NECTIN2 SDK1 ICAM1 FCRL5 | 7.04e-06 | 193 | 192 | 11 | 594 |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 6.24e-05 | 40 | 192 | 5 | 592 | |
| GeneFamily | WD repeat domain containing | DCAF12L2 CIAO1 WDFY1 WDR5B WDR27 WDR5 PREB DCAF12L1 CSTF1 WDFY3 LRBA | 1.17e-04 | 262 | 192 | 11 | 362 |
| GeneFamily | Fibronectin type III domain containing | 3.15e-04 | 160 | 192 | 8 | 555 | |
| GeneFamily | Phosphoinositide phosphatases | 3.51e-04 | 32 | 192 | 4 | 1079 | |
| GeneFamily | Myotubularins|Phosphoinositide phosphatases | 4.88e-04 | 15 | 192 | 3 | 903 | |
| GeneFamily | Chloride channel accessory | 6.64e-04 | 4 | 192 | 2 | 867 | |
| GeneFamily | Cadherin related | 7.18e-04 | 17 | 192 | 3 | 24 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 1.81e-03 | 163 | 192 | 7 | 590 | |
| GeneFamily | Sterile alpha motif domain containing | 2.46e-03 | 88 | 192 | 5 | 760 | |
| GeneFamily | Fibulins | 3.01e-03 | 8 | 192 | 2 | 556 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 3.85e-03 | 9 | 192 | 2 | 1230 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 4.26e-03 | 31 | 192 | 3 | 81 | |
| GeneFamily | Ankyrin repeat domain containing | 4.41e-03 | 242 | 192 | 8 | 403 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 5.32e-03 | 66 | 192 | 4 | 722 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ATRX TRIO CENPE FAT1 BRCA2 SYNJ2 VPS13A ARID5B MTMR3 SMURF2 WWC1 SASH1 NUP98 MED13L KIF20B NR2F2 IBTK TIAM1 GCC2 SIPA1L1 WDFY3 MTREX PCCA HERC4 | 4.65e-06 | 856 | 258 | 24 | M4500 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | FAM185A SENP3 TASOR2 FANCD2 ZNF462 BRCA2 NAE1 BUB1 VPS13A ETAA1 DKC1 HERC3 DDX4 ASZ1 HEATR5A WDR5 CEP192 REST CPNE5 KIF20B DARS2 GSR ORC1 THADA MEIOC CBFA2T2 PRKDC MORC3 ESPL1 | 2.25e-07 | 822 | 255 | 29 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | SETD1A ATRX CENPE ASH1L BIRC6 ZNF462 TNRC18 CLCA1 DKC1 SMURF2 DDX4 ASZ1 PNLIPRP2 REST NR2F2 PPP2R1A DEPDC5 SCAF11 WDFY3 | 4.65e-07 | 403 | 255 | 19 | gudmap_developingGonad_e12.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | SETD1A ZNF266 ATRX CENPE ASH1L GDI1 BIRC6 RYR2 CLCA1 ARID5B DKC1 ANKRD12 SMURF2 DDX4 PLXNA2 ASZ1 PNLIPRP2 AHCYL2 REST PPBP NR2F2 PPP2R1A DCAF12L1 RHEBL1 DEPDC5 SCAF11 WDFY3 MORC3 | 4.78e-07 | 804 | 255 | 28 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | FAM185A TKTL1 TASOR2 FANCD2 BRCA2 NAE1 HACE1 BUB1 VPS13A DKC1 ATP11C HERC3 ANKRD12 DDX4 ASZ1 WDR5 CEP192 CPNE5 TDRD1 DARS2 ORC1 MEIOC CARF PRKDC LRBA MORC3 ESPL1 TCFL5 | 7.07e-07 | 820 | 255 | 28 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | CADM3 FAM185A ATRX CENPE ZNF423 FANCD2 ZNF462 TTC8 CCDC66 ZIK1 NRXN1 BRCA2 OSGEPL1 BUB1 VPS13A SLMAP ATP11C HERC3 KLK14 ZDBF2 CEP192 TXNRD2 TDRD1 KIF20B ORC1 CELSR2 GCC2 CBFA2T2 PAPPA TRIM40 PCCA | 4.47e-06 | 1060 | 255 | 31 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | SETD1A ATRX ASH1L TKTL1 BIRC6 RYR2 TASOR2 CLCA1 BRCA2 BUB1 VPS13A ATP11C HERC3 ANKRD12 SMURF2 DDX4 ASZ1 AHCYL2 PPP2R1A DCAF12L1 HMCN1 MEIOC DEPDC5 MORC3 TCFL5 | 7.94e-06 | 776 | 255 | 25 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | SETD1A ATRX CENPE ASH1L BIRC6 ZNF462 TNRC18 CLCA1 GLG1 ARID5B DKC1 TACC1 SMURF2 DDX4 ASZ1 PNLIPRP2 AHCYL2 REST NR2F2 PPP2R1A RHEBL1 DEPDC5 SCAF11 WDFY3 TCFL5 | 1.51e-05 | 806 | 255 | 25 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | SENP3 FANCD2 BUB1 DKC1 HERC3 DDX4 ASZ1 HEATR5A WDR5 CEP192 ORC1 MORC3 ESPL1 | 2.15e-05 | 266 | 255 | 13 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k2_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | SETD1A ATRX GBP7 ASH1L TKTL1 WNK1 BIRC6 RYR2 ATP11C HERC3 ANKRD12 SMURF2 DDX4 ASZ1 AHCYL2 REST AR PPP2R1A DCAF12L1 HMCN1 MEIOC SCAF11 WDFY3 TCFL5 | 2.46e-05 | 778 | 255 | 24 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | FAM185A SENP3 FANCD2 BRCA2 NAE1 BUB1 ETAA1 DKC1 HERC3 DDX4 ASZ1 HEATR5A WDR5 CEP192 REST KIF20B DARS2 GSR ORC1 CBFA2T2 RHEBL1 PRKDC MORC3 ESPL1 | 3.47e-05 | 795 | 255 | 24 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | FAM185A SENP3 TASOR2 FANCD2 BRCA2 NAE1 BUB1 HERC3 ANKRD12 DDX4 ASZ1 HEATR5A WDR5 CEP192 TDRD1 KIF20B DARS2 ORC1 THADA PRKDC MORC3 MTREX ESPL1 TCFL5 | 4.67e-05 | 810 | 255 | 24 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | SENP3 FANCD2 BUB1 HERC3 DDX4 ASZ1 HEATR5A WDR5 CEP192 ORC1 THADA MORC3 MTREX ESPL1 | 5.46e-05 | 333 | 255 | 14 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500 | SETD1A ATRX ASH1L TKTL1 BIRC6 RYR2 ANKRD12 SMURF2 DDX4 ASZ1 AHCYL2 PPP2R1A DCAF12L1 MEIOC TCFL5 | 6.44e-05 | 382 | 255 | 15 | gudmap_developingGonad_e14.5_ ovary_500 |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_1000 | FAM185A HMCES FANCD2 BRCA2 BUB1 ETAA1 DKC1 HERC3 DDX4 ASZ1 WDR5 CEP192 REST KIF20B DARS2 GSR ORC1 CBFA2T2 RHEBL1 CSTF1 PRKDC MORC3 ESPL1 | 7.39e-05 | 781 | 255 | 23 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500 | 8.60e-05 | 150 | 255 | 9 | gudmap_developingGonad_e12.5_epididymis_k5_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | SETD1A ATRX TRIO ASH1L BIRC6 ZNF462 BMP1 TNRC18 GLG1 ARID5B COL14A1 ANKRD12 SMURF2 PLXNA2 ARAP1 AHCYL2 REST AR NR2F2 PPP2R1A DEPDC5 SCAF11 WDFY3 | 8.77e-05 | 790 | 255 | 23 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | SETD1A ATRX GBP7 TRIO ASH1L GDI1 BIRC6 ZNF462 TNRC18 GLG1 ARID5B COL14A1 ANKRD12 SMURF2 PLXNA2 ADAMTSL1 AHCYL2 AR NR2F2 PPP2R1A DEPDC5 SCAF11 WDFY3 | 1.04e-04 | 799 | 255 | 23 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | SETD1A ATRX TRIO ASH1L GDI1 BIRC6 ZNF462 TNRC18 GLG1 ARID5B ANKRD12 SMURF2 DDX4 PLXNA2 ARAP1 AHCYL2 REST AR NR2F2 PPP2R1A DEPDC5 SCAF11 WDFY3 | 1.08e-04 | 801 | 255 | 23 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_200 | 1.11e-04 | 155 | 255 | 9 | gudmap_developingGonad_e16.5_ovary_200 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | SETD1A ZNF266 ATRX CENPE ASH1L GDI1 BIRC6 ZNF462 ARID5B DKC1 SMURF2 DDX4 PLXNA2 ANGPT1 PNLIPRP2 AHCYL2 REST PPBP NR2F2 PPP2R1A DEPDC5 SCAF11 WDFY3 | 1.39e-04 | 815 | 255 | 23 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | SETD1A ATRX ASH1L GDI1 ARID5B DKC1 SMURF2 PLXNA2 AHCYL2 NR2F2 DEPDC5 WDFY3 | 1.40e-04 | 277 | 255 | 12 | gudmap_developingGonad_e12.5_ovary_k3_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 1.55e-04 | 162 | 255 | 9 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | SETD1A ZNF266 ATRX CENPE ASH1L GDI1 ARID5B DKC1 SMURF2 PLXNA2 AHCYL2 DEPDC5 WDFY3 | 1.55e-04 | 323 | 255 | 13 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | SETD1A ATRX CENPE ASH1L TKTL1 WNK1 BIRC6 PPM1H RYR2 HERC3 ANKRD12 DDX4 ANO4 ASZ1 REST AR PPP2R1A DCAF12L1 RHEBL1 SCAF11 WDFY3 TCFL5 | 1.64e-04 | 770 | 255 | 22 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500 | SETD1A ATRX ASH1L GDI1 BIRC6 ZNF462 DDX4 PLXNA2 PNLIPRP2 AHCYL2 PPBP NR2F2 PPP2R1A DEPDC5 WDFY3 | 1.69e-04 | 417 | 255 | 15 | gudmap_developingGonad_e11.5_ovary + mesonephros_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_100 | 1.95e-04 | 70 | 255 | 6 | gudmap_developingGonad_e14.5_ ovary_100 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_500 | SETD1A ATRX TKTL1 BIRC6 PPM1H RYR2 HERC3 ANKRD12 DDX4 ASZ1 AR PPP2R1A DCAF12L1 TCFL5 | 2.12e-04 | 379 | 255 | 14 | gudmap_developingGonad_P2_ovary_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500 | TKTL1 TASOR2 FANCD2 BRCA2 NAE1 BUB1 VPS13A HERC3 DDX4 ASZ1 ORC1 MEIOC PRKDC ESPL1 | 2.49e-04 | 385 | 255 | 14 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | SETD1A ATRX GBP7 ASH1L TKTL1 BIRC6 RYR2 CLCA1 GLG1 ANKRD12 SMURF2 DDX4 ASZ1 AHCYL2 PPP2R1A DCAF12L1 HMCN1 MEIOC DEPDC5 SCAF11 WDFY3 TCFL5 | 2.55e-04 | 795 | 255 | 22 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | SETD1A ATRX ASH1L TKTL1 BIRC6 RYR2 ANKRD12 SMURF2 DDX4 ASZ1 PPP2R1A DCAF12L1 MEIOC TCFL5 | 2.63e-04 | 387 | 255 | 14 | gudmap_developingGonad_e18.5_ovary_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#2_top-relative-expression-ranked_100 | 2.63e-04 | 11 | 255 | 3 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k2_100 | |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | FANCD2 BUB1 DKC1 HERC3 DDX4 ASZ1 WDR5 CEP192 KIF20B MORC3 ESPL1 | 3.04e-04 | 258 | 255 | 11 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_k2_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | SETD1A ATRX ASH1L TNRC18 ARID5B DKC1 SMURF2 AHCYL2 NR2F2 DEPDC5 WDFY3 | 3.14e-04 | 259 | 255 | 11 | gudmap_developingGonad_e12.5_epididymis_k3_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#3_top-relative-expression-ranked_500 | 3.78e-04 | 79 | 255 | 6 | gudmap_developingGonad_P2_ovary_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_200 | 4.11e-04 | 147 | 255 | 8 | gudmap_developingGonad_e18.5_ovary_200 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | CADM3 FAM185A ATRX CENPE ZNF423 FANCD2 ZNF462 TTC8 CCDC66 ZIK1 NRXN1 BRCA2 OSGEPL1 BUB1 VPS13A SLMAP ATP11C HERC3 HERC6 KLK14 ZDBF2 CEP192 TXNRD2 TDRD1 KIF20B ORC1 CELSR2 GCC2 CBFA2T2 PAPPA TRIM40 PCCA | 4.17e-04 | 1414 | 255 | 32 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#1_top-relative-expression-ranked_100 | 4.48e-04 | 13 | 255 | 3 | gudmap_developingGonad_e14.5_ ovary_100_k1 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | FANCD2 BRCA2 NAE1 BUB1 DKC1 DDX4 ASZ1 WDR5 CEP192 CPNE5 ORC1 MORC3 ESPL1 | 4.52e-04 | 361 | 255 | 13 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | SETD1A ATRX CENPE ASH1L BIRC6 SMURF2 DDX4 ASZ1 PNLIPRP2 AHCYL2 NR2F2 PPP2R1A DCAF12L1 DEPDC5 | 4.57e-04 | 409 | 255 | 14 | gudmap_developingGonad_e12.5_ovary_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.83e-04 | 115 | 255 | 7 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k2_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K0 | 5.26e-04 | 84 | 255 | 6 | facebase_RNAseq_e10.5_MandArch_2500_K0 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | SETD1A ATRX ASH1L GDI1 TNRC18 ARID5B SMURF2 PLXNA2 NR2F2 DEPDC5 WDFY3 | 6.23e-04 | 281 | 255 | 11 | gudmap_developingGonad_e18.5_epididymis_1000_k3 |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_500 | FAM185A FANCD2 BRCA2 BUB1 ETAA1 HERC3 DDX4 ASZ1 KIF20B DARS2 GSR ORC1 CBFA2T2 | 6.62e-04 | 376 | 255 | 13 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_1000 | FAM185A HMCES FANCD2 BRCA2 BUB1 ETAA1 DKC1 AK1 HERC3 DDX4 ASZ1 CEP192 REST KIF20B DARS2 GSR ORC1 CBFA2T2 RHEBL1 MORC3 ESPL1 | 6.88e-04 | 799 | 255 | 21 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_200 | 7.10e-04 | 34 | 255 | 4 | gudmap_developingGonad_e18.5_ovary_200_k2 | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | ATRX ASH1L ADAR IFIH1 ARID5B ANKRD12 HERC6 DDX24 THEMIS GCC2 IGLC2 IGLC3 FCRL5 | 1.80e-10 | 199 | 259 | 13 | 952fac67588ad5676f5939e3c7f8bac803c27064 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA13 OBSCN RYR2 FAT1 NRXN1 SCN2A SDK1 ATP13A4 PKHD1L1 HMCN1 EPHA10 EPHA5 | 9.32e-10 | 184 | 259 | 12 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA13 OBSCN RYR2 FAT1 NRXN1 SCN2A SDK1 ATP13A4 PKHD1L1 HMCN1 EPHA10 EPHA5 | 9.32e-10 | 184 | 259 | 12 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA13 OBSCN RYR2 FAT1 NRXN1 SCN2A SDK1 ATP13A4 PKHD1L1 HMCN1 EPHA10 EPHA5 | 9.32e-10 | 184 | 259 | 12 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ADGRE2 RYR2 PTPRS COL14A1 SDK1 ACSS3 CACNA1D ANGPT1 AOX1 ADAMTS8 PAPPA FRMD3 | 1.27e-09 | 189 | 259 | 12 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | ATRX BIRC6 TASOR2 WDFY1 ACTR8 HEATR5A DENND4C GCC2 SBF2 SCAF11 PRKDC WDFY3 | 1.61e-09 | 193 | 259 | 12 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 |
| ToppCell | Dividing_Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | ATRX CENPE BRCA2 BUB1 PRSS45P RCCD1 PPBP KIF20B ORC1 POLQ ESPL1 | 3.99e-09 | 166 | 259 | 11 | c503036f3c19ef186e1e62c9643c49dea3827f51 |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | SPEG RYR2 IGSF10 PTPRS COL14A1 SDK1 ANO4 CACNA1D ANGPT1 NR2F2 PAPPA | 1.72e-08 | 191 | 259 | 11 | 14057205ddb9b4bbc582d1358d13cf36d979a61b |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | WNK1 SYNJ2 TACC1 SDK1 ACSS3 MED13L GCC2 CBFA2T2 INSIG2 SCAF11 MTREX | 1.82e-08 | 192 | 259 | 11 | 916fbec1c7ab7969bda711886ac88e877e30c280 |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | RYR2 IGSF10 COL14A1 SDK1 ACSS3 CACNA1D ANGPT1 AOX1 ADAMTS8 PAPPA FRMD3 | 1.82e-08 | 192 | 259 | 11 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | WNK1 SYNJ2 TACC1 SDK1 ACSS3 MED13L GCC2 INSIG2 SCAF11 LRBA MTREX | 1.92e-08 | 193 | 259 | 11 | e6a688bc834f845ff64dae1be64f073eec5091a1 |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | RYR2 IGSF10 PTPRS SDK1 CACNA1D ANGPT1 AOX1 ADAMTS8 NR2F2 HMCN1 RANBP3L | 2.13e-08 | 195 | 259 | 11 | aa0add081881d349099d12efca5cdee098038d4e |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | CENPE ABCA13 FANCD2 SERPINB5 BRCA2 BUB1 SDK1 KIF20B ORC1 POLQ ESPL1 | 2.50e-08 | 198 | 259 | 11 | f088badb90c6c2d916195f5649eda102119c9ac6 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | CLSTN3 RYR2 IGSF10 ARID5B COL14A1 SDK1 ANGPT1 AOX1 ADAMTS8 PAPPA FRMD3 | 2.63e-08 | 199 | 259 | 11 | 8b86c69aaf60feff53aa782559cfece7342a23de |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 7.10e-08 | 172 | 259 | 10 | da959c1abadafd79b7a0088a25eb8ef8efa3a0c2 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | RYR2 IGSF10 TTC8 COL14A1 SDK1 ACSS3 CACNA1D ANGPT1 TIAM1 FRMD3 | 1.09e-07 | 180 | 259 | 10 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | RYR2 IGSF10 COL14A1 SDK1 ACSS3 CACNA1D ANGPT1 AOX1 ADAMTS8 PAPPA | 1.89e-07 | 191 | 259 | 10 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | NBL1 RYR2 PTPRS SDK1 CACNA1D ANGPT1 AOX1 ADAMTS8 HMCN1 RANBP3L | 1.89e-07 | 191 | 259 | 10 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | RYR2 IGSF10 COL14A1 SDK1 ACSS3 CACNA1D ANGPT1 AOX1 ADAMTS8 NR2F2 | 1.98e-07 | 192 | 259 | 10 | 3d0cb19f037f604253d7d728689aeaa94251e92b |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ADGRE2 RYR2 COL14A1 SDK1 CACNA1D ANGPT1 AOX1 ADAMTS8 TIAM1 PAPPA | 1.98e-07 | 192 | 259 | 10 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | NBL1 RYR2 PTPRS SDK1 CACNA1D ANGPT1 AOX1 ADAMTS8 HMCN1 RANBP3L | 1.98e-07 | 192 | 259 | 10 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | NBL1 RYR2 PTPRS SDK1 CACNA1D ANGPT1 ADAMTS8 NR2F2 HMCN1 RANBP3L | 2.08e-07 | 193 | 259 | 10 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | RYR2 IGSF10 PTPRS COL14A1 SDK1 ACSS3 CACNA1D ANGPT1 ADAMTS8 NR2F2 | 2.18e-07 | 194 | 259 | 10 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | RYR2 IGSF10 PTPRS COL14A1 SDK1 CACNA1D ANGPT1 AOX1 ADAMTS8 HMCN1 | 2.40e-07 | 196 | 259 | 10 | bc94909f9b2dc08a59eef1914148b69720569c8f |
| ToppCell | (3)_DC_Monocyte_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.64e-07 | 198 | 259 | 10 | e2b89f6d7c0007ccab62495cd543fe0e5513a9a4 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | NBL1 RYR2 PTPRS COL14A1 SDK1 CACNA1D ANGPT1 AOX1 HMCN1 PAPPA | 2.64e-07 | 198 | 259 | 10 | df3de77216f5c5d6141ec44d01c56b942f611838 |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A2|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.87e-07 | 111 | 259 | 8 | dfbdeadad321392d359e6fb7112b28b043a4b874 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | NBL1 RYR2 IGSF10 PTPRS CACNA1D ANGPT1 ADAMTS8 NR2F2 HMCN1 RANBP3L | 2.90e-07 | 200 | 259 | 10 | aa1a35dcca3b799241eef4237f6eb94660e019f0 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | NBL1 RYR2 IGSF10 PTPRS CACNA1D ANGPT1 ADAMTS8 NR2F2 HMCN1 RANBP3L | 2.90e-07 | 200 | 259 | 10 | a510deaada669e690329183e18df02870bd204b3 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | NBL1 RYR2 IGSF10 PTPRS CACNA1D ANGPT1 ADAMTS8 NR2F2 HMCN1 RANBP3L | 2.90e-07 | 200 | 259 | 10 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.74e-07 | 162 | 259 | 9 | 7a05b05a33e1309fb5c0a8171db105ae68491815 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.74e-07 | 162 | 259 | 9 | 8ed9149ff53b285591354057055d072b203a47c8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.13e-07 | 167 | 259 | 9 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.50e-07 | 176 | 259 | 9 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 10x5'-Liver-Lymphocytic_B_plasma-Plasmablasts|Liver / Manually curated celltypes from each tissue | 9.96e-07 | 177 | 259 | 9 | 1d88ae316d65ca5fdc736c9da93885b6b40c32bb | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-06 | 180 | 259 | 9 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B_plasma-Plasma_cells|GI_small-bowel / Manually curated celltypes from each tissue | PLEKHH3 ARID5B CARMIL1 CPNE5 PKHD1L1 IGLC1 IGLC2 IGLC3 FCRL5 | 1.31e-06 | 183 | 259 | 9 | ab5aaafcfd7b97330be6774be4c72611ca85257c |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B_plasma|GI_small-bowel / Manually curated celltypes from each tissue | PLEKHH3 ARID5B CARMIL1 CPNE5 PKHD1L1 IGLC1 IGLC2 IGLC3 FCRL5 | 1.31e-06 | 183 | 259 | 9 | 193bfb787c1b36c8fabf4b00fafb5b398de6b999 |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.57e-06 | 187 | 259 | 9 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | PPM1H TACC1 PLXNA2 ADAMTSL1 SASH1 PCDH11Y TECTA PKHD1L1 HMCN1 | 1.57e-06 | 187 | 259 | 9 | 7876dcb4800c2e54874df3d933efb79307a64a97 |
| ToppCell | Cerebellum-Neuronal|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.57e-06 | 187 | 259 | 9 | 61b9d6eb131a674598aa8409d7fa909c8765442d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.79e-06 | 190 | 259 | 9 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.79e-06 | 190 | 259 | 9 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.79e-06 | 190 | 259 | 9 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.87e-06 | 191 | 259 | 9 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-06 | 192 | 259 | 9 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.95e-06 | 192 | 259 | 9 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.97e-06 | 143 | 259 | 8 | 8f897278f9ccc82ae35e4f30c5f930b2a3eb509d | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-06 | 193 | 259 | 9 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-06 | 193 | 259 | 9 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-06 | 193 | 259 | 9 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.13e-06 | 194 | 259 | 9 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.13e-06 | 194 | 259 | 9 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.13e-06 | 194 | 259 | 9 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.13e-06 | 194 | 259 | 9 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.22e-06 | 195 | 259 | 9 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.22e-06 | 195 | 259 | 9 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 2.22e-06 | 195 | 259 | 9 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.22e-06 | 195 | 259 | 9 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.31e-06 | 196 | 259 | 9 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.31e-06 | 196 | 259 | 9 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | RYR2 IGSF10 ARID5B COL14A1 ANGPT1 ADAMTS8 ALPK1 CBFA2T2 PAPPA | 2.41e-06 | 197 | 259 | 9 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.41e-06 | 197 | 259 | 9 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.41e-06 | 197 | 259 | 9 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.41e-06 | 197 | 259 | 9 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | AT2_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 2.41e-06 | 197 | 259 | 9 | 8b5d4e1c33a57c899c51feb9a6f347232f8910a3 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 2.52e-06 | 198 | 259 | 9 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | distal-1-Hematologic-Proliferating_Macrophage|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.52e-06 | 198 | 259 | 9 | df3f5559ecd1f3cd1fd60e39dbad8741309e83a3 | |
| ToppCell | (0)_NK_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.52e-06 | 198 | 259 | 9 | 5ebb4965b723302152b42bfaf48bb77a57dd02c5 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.52e-06 | 198 | 259 | 9 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | MNPs-Dividing_Macrophages|MNPs / lung cells shred on cell class, cell subclass, sample id | 2.62e-06 | 199 | 259 | 9 | 5952980d0ece5d73f3e9f340c56a38b34d2f2309 | |
| ToppCell | Dividing_Macrophages|World / lung cells shred on cell class, cell subclass, sample id | 2.62e-06 | 199 | 259 | 9 | 5c755b6876e164dc847ef7c723f850f227cf3a87 | |
| ToppCell | Mild-T/NK_proliferative|Mild / Disease group and Cell class | 2.62e-06 | 199 | 259 | 9 | 64a5c91243ee999ea21ffddd450d3e5fdbf6470b | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.62e-06 | 199 | 259 | 9 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 2.62e-06 | 199 | 259 | 9 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 2.62e-06 | 199 | 259 | 9 | e222b90caf45904d8f763574e7b6aac13333df92 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | IGSF10 ARID5B COL14A1 SDK1 CACNA1D ANGPT1 AOX1 ADAMTS8 ALPK1 | 2.73e-06 | 200 | 259 | 9 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 |
| ToppCell | Biopsy_Control_(H.)-Immune-Proliferating_Macrophages|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.73e-06 | 200 | 259 | 9 | ce9fad55f779afd3d6c5a9c5a15e2d9f548b7c7e | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.73e-06 | 200 | 259 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.73e-06 | 200 | 259 | 9 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Biopsy_Other_PF-Immune-Proliferating_Macrophages|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.73e-06 | 200 | 259 | 9 | 61473e8613f39a92002d5b631e6bd563735566e4 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | ADGRE2 RYR2 ARID5B COL14A1 CACNA1D ANGPT1 AOX1 ADAMTS8 ALPK1 | 2.73e-06 | 200 | 259 | 9 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 |
| ToppCell | Biopsy_IPF-Immune-Proliferating_Macrophages|Biopsy_IPF / Sample group, Lineage and Cell type | 2.73e-06 | 200 | 259 | 9 | 8abb2c25422717e994468ac02d8260344341467f | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.73e-06 | 200 | 259 | 9 | e4eb915c29909cf8535a3603c68976545c05e54b | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte-|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.73e-06 | 200 | 259 | 9 | 415e7556b5ac45688e2c6c30a52bd40e0eb27c7d | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.73e-06 | 200 | 259 | 9 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 2.73e-06 | 200 | 259 | 9 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.73e-06 | 200 | 259 | 9 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.21e-06 | 163 | 259 | 8 | 3f434015c0cbefb31eeda133c34f75384c5f7e22 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B_plasma-Plasmablasts|bone_marrow / Manually curated celltypes from each tissue | 5.45e-06 | 164 | 259 | 8 | 67260e9f569f0acaeb0e65f69cde230f91cd3d26 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.70e-06 | 165 | 259 | 8 | eec2d327c94832d1390314c93ef6a2be4648478b | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G-|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.51e-06 | 168 | 259 | 8 | b8c65542a0701ae31f49d332d87a64578e24b4e3 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.51e-06 | 168 | 259 | 8 | 8c95093b1ea45826f62893edd3c410fe53b563a4 | |
| ToppCell | IIH-naiveBc|IIH / Condition, Cell_class and T cell subcluster | 6.51e-06 | 168 | 259 | 8 | 8450ed6720d308c711dfbc76652e5821be7b8e93 | |
| ToppCell | IIH-naiveBc-|IIH / Condition, Cell_class and T cell subcluster | 6.51e-06 | 168 | 259 | 8 | 27b500f79aedc4669988670c92ff1a47dcbdf2a0 | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.80e-06 | 169 | 259 | 8 | 89fbafdb4628ce7a90c50398870e0f8ee90cfd91 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B_plasma|Lung / Manually curated celltypes from each tissue | 6.80e-06 | 169 | 259 | 8 | a65853ff9f6489cc1617cbba0d03b392d23c1528 | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.80e-06 | 169 | 259 | 8 | 9ab34f602d46ce87283d243b81621e8806504f43 | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.80e-06 | 169 | 259 | 8 | 75d367eb35768d3063096e8866cea649dac3b1bd | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.10e-06 | 170 | 259 | 8 | 7dcb6319ba4d7b258dd0a17449d837800ef46ccc | |
| Drug | Disulfiram [97-77-8]; Down 200; 13.4uM; MCF7; HT_HG-U133A | ATRX SENP3 SYNJ2 OSGEPL1 PVR BUB1 CASP2 AHCYL2 AR NR2F2 RBM12 CBFA2T2 PCCA | 2.99e-07 | 194 | 254 | 13 | 6210_DN |
| Drug | Methoxy-6-harmalan [3589-73-9]; Down 200; 18.6uM; MCF7; HT_HG-U133A | SETD1A WNK1 PIK3R2 PVR PLAU SASH1 ICAM1 SMURF1 CASP2 ALPK1 CBFA2T2 SIPA1L1 WDFY3 | 3.18e-07 | 195 | 254 | 13 | 5455_DN |
| Drug | prochloraz | CD164 HMCES TNRC18 SHC2 NRXN1 GLS AK1 NME3 ACSS3 CACNA1D PPEF1 AR GFM2 GSR CSTF1 | 3.77e-07 | 268 | 254 | 15 | ctd:C045362 |
| Drug | Xylometazoline hydrochloride [1218-35-5]; Down 200; 14.2uM; MCF7; HT_HG-U133A | SETD1A NR4A1 RYR2 GLG1 PIK3R2 AK1 PLAU TACC1 HERC6 GRIK5 AHCYL2 TDRD1 AR | 4.01e-07 | 199 | 254 | 13 | 2270_DN |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | TPTE TRIO CENPE PPM1H ARID5B ANKRD12 NUP98 MED13L GTF2IRD1 KIF20B TIAM1 WDFY3 | 6.34e-07 | 174 | 254 | 12 | 7530_DN |
| Drug | Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | CENPE VPS13A TACC1 ANKRD12 NUP98 AR KIF20B DENND4C PCNX4 WDFY3 HERC4 SLC6A14 | 9.09e-07 | 180 | 254 | 12 | 2859_DN |
| Drug | Tropicamide [1508-75-4]; Down 200; 14uM; PC3; HT_HG-U133A | SETD1A WNK1 SYNJ2 GLG1 AK1 HERC6 ACSS3 CASP2 ALPK1 REST NR2F2 HERC4 | 1.90e-06 | 193 | 254 | 12 | 4280_DN |
| Drug | Pimethixene maleate [13187-06-9]; Down 200; 9.8uM; MCF7; HT_HG-U133A | SETD1A ZBTB6 BRCA2 GLS ETAA1 MTMR2 TACC1 WWC1 ACTR8 CARMIL1 AHCYL2 AR | 2.00e-06 | 194 | 254 | 12 | 7468_DN |
| Drug | Capsaicin [404-86-4]; Up 200; 13uM; MCF7; HT_HG-U133A | NR4A1 RYR2 BMP1 SHC2 PVR APOBEC3C ARAP1 HUS1 CASP2 GRIK5 REST CD80 | 2.23e-06 | 196 | 254 | 12 | 3372_UP |
| Drug | Carbimazole [22232-54-8]; Down 200; 21.4uM; MCF7; HT_HG-U133A | WNK1 RYR2 BMP1 GLG1 PVR VPS13A AK1 TACC1 HUS1 ICAM1 CASP2 ALPK1 | 2.35e-06 | 197 | 254 | 12 | 3299_DN |
| Drug | Eserine sulfate, physostigmine sulfate [64-47-1]; Up 200; 6.2uM; MCF7; HT_HG-U133A | TRIO ATG2A NR4A1 BMP1 CLCA1 SYNJ2 AK1 HERC3 GRIK5 NLRP2 THAP9 WDFY3 | 2.48e-06 | 198 | 254 | 12 | 2768_UP |
| Drug | rofecoxib; Up 200; 10uM; MCF7; HG-U133A | NR4A1 PTPRS GLS RIPOR1 WWC1 ICAM1 AOX1 GRIK5 AHCYL2 ALPK1 SIPA1L1 WDFY3 | 2.75e-06 | 200 | 254 | 12 | 251_UP |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | OSGEPL1 BUB1 ARID5B RIPOR1 TACC1 SASH1 NUP98 NR2F2 ESPL1 ZMYM3 SLC6A14 | 9.11e-06 | 188 | 254 | 11 | 6451_DN |
| Drug | Promethazine hydrochloride [58-33-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | ZBTB6 SPEG BRCA2 SYNJ2 GLS BUB1 APOBEC3C CASP2 ORC1 PKP3 HERC4 | 9.58e-06 | 189 | 254 | 11 | 6717_DN |
| Drug | Equilin [474-86-2]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.23e-05 | 194 | 254 | 11 | 3377_DN | |
| Drug | Acemetacin [53164-05-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A | NR4A1 BMP1 PVR RIPOR1 PLAU ARAP1 SMURF1 GRIK5 AHCYL2 CBFA2T2 SIPA1L1 | 1.29e-05 | 195 | 254 | 11 | 5460_DN |
| Drug | PF-00539745-00 [351321-33-0]; Down 200; 10uM; MCF7; HT_HG-U133A | CADM3 ZNF423 BMP1 PTPRS CNTN5 GLS AK1 CACNA1D GRIK5 PKP3 MUC5AC | 1.35e-05 | 196 | 254 | 11 | 5974_DN |
| Drug | Diphemanil methylsulfate [62-97-5]; Up 200; 10.2uM; PC3; HG-U133A | PPM1H GLG1 CIAO1 PVR RIPOR1 TACC1 NME3 ICAM1 ALPK1 PPBP MTREX | 1.35e-05 | 196 | 254 | 11 | 1912_UP |
| Drug | Sisomicin sulfate [53179-09-2]; Up 200; 2.8uM; MCF7; HT_HG-U133A | CLSTN3 SPEG BMP1 BUB1 ETAA1 ANGPT1 ICAM1 CASP2 CBFA2T2 PAPPA DEPDC5 | 1.48e-05 | 198 | 254 | 11 | 4132_UP |
| Drug | Chlorpheniramine maleate [113-92-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A | SETD1A WNK1 RYR2 IFIH1 BMP1 PTPRS PIK3R2 GRIK5 REST TIAM1 HERC4 | 1.48e-05 | 198 | 254 | 11 | 2217_DN |
| Drug | Antipyrine [60-80-0]; Up 200; 21.2uM; MCF7; HT_HG-U133A | SETD1A ATRX ASH1L NR4A1 RYR2 BMP1 SYNJ2 CNTN5 AK1 SASH1 ALPK1 | 1.48e-05 | 198 | 254 | 11 | 1489_UP |
| Drug | tamoxifen citrate; Down 200; 1uM; MCF7; HG-U133A | CADM3 WNK1 BMP1 CEACAM21 OSGEPL1 HERC3 ANKRD12 WWC1 FSCN3 ICAM1 DENND4C | 1.56e-05 | 199 | 254 | 11 | 380_DN |
| Drug | colchicine; Down 200; 0.1uM; MCF7; HG-U133A | ZNF266 NR4A1 WNK1 BMP1 PVR GRIK5 MED13L KIF20B IBTK THADA CD80 | 1.56e-05 | 199 | 254 | 11 | 644_DN |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Down 200; 23.6uM; MCF7; HT_HG-U133A | SETD1A ATG2A NR4A1 BMP1 PIK3R2 PVR MTMR3 ETAA1 CASP2 NR2F2 FAN1 | 1.63e-05 | 200 | 254 | 11 | 5996_DN |
| Drug | Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 4.80e-05 | 186 | 254 | 10 | 5000_DN | |
| Drug | Convolamine hydrochloride [500-56-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 6.00e-05 | 191 | 254 | 10 | 2771_UP | |
| Drug | Cotinine (-) [486-56-6]; Down 200; 22.6uM; PC3; HG-U133A | CD164 GLS TACC1 SASH1 MED13L KIF20B RBM12 SCAF11 PRKDC MORC3 | 6.27e-05 | 192 | 254 | 10 | 1929_DN |
| Drug | 2-Aminobenzenesulfonamide [3306-62-5]; Down 200; 23.2uM; MCF7; HT_HG-U133A | 6.27e-05 | 192 | 254 | 10 | 3400_DN | |
| Drug | Methyl benzethonium chloride [25155-18-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A | ZBTB6 OSGEPL1 MTMR3 HERC6 ACTR8 CASP2 DNAAF2 RBM12 CBFA2T2 POLQ | 6.55e-05 | 193 | 254 | 10 | 3943_DN |
| Drug | Felodipine [72509-76-3]; Down 200; 10.4uM; HL60; HT_HG-U133A | SENP3 WNK1 ETAA1 HERC3 HERC6 ACTR8 ICAM1 CASP2 NR2F2 DENND4C | 6.84e-05 | 194 | 254 | 10 | 2433_DN |
| Drug | Spironolactone [52-01-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A | BMP1 RIPOR1 ANKRD12 ACTR8 HUS1 SMURF1 NR2F2 TIAM1 SMARCC2 MORC3 | 7.14e-05 | 195 | 254 | 10 | 6255_DN |
| Drug | oxaprozin; Down 200; 300uM; MCF7; HT_HG-U133A_EA | 7.14e-05 | 195 | 254 | 10 | 863_DN | |
| Drug | BW-B 70C; Down 200; 31.6uM; MCF7; HT_HG-U133A_EA | ATRX OSGEPL1 CIAO1 ARID5B TACC1 NUP98 NR2F2 ORC1 SCAF11 HERC4 | 7.14e-05 | 195 | 254 | 10 | 1132_DN |
| Drug | Rescinnamin [24815-24-5]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 7.14e-05 | 195 | 254 | 10 | 4386_DN | |
| Drug | Clorsulon [60200-06-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | SETD1A DCHS2 SYNJ2 PTPRS HERC6 PLXNA2 CACNA1D SASH1 GRIK5 ALPK1 | 7.45e-05 | 196 | 254 | 10 | 7025_UP |
| Drug | Nomegestrol acetate [58652-20-3]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 7.45e-05 | 196 | 254 | 10 | 5461_DN | |
| Drug | Kaempferol [520-18-3]; Up 200; 14uM; MCF7; HT_HG-U133A | SENP3 SPTBN5 BMP1 SYNJ2 CIAO1 BUB1 HERC6 CACNA1D ANGPT1 SIPA1L1 | 7.45e-05 | 196 | 254 | 10 | 3579_UP |
| Drug | Chrysene-1,4-quinone [100900-16-1]; Down 200; 15.4uM; PC3; HT_HG-U133A | BRCA2 OSGEPL1 MTMR3 TACC1 CASP2 NR2F2 DNAAF2 RBM12 PAXIP1 ESPL1 | 7.45e-05 | 196 | 254 | 10 | 7139_DN |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A | 7.77e-05 | 197 | 254 | 10 | 6930_DN | |
| Drug | Alclometasone dipropionate [667634-13-2]; Down 200; 7.6uM; MCF7; HT_HG-U133A | BRCA2 SYNJ2 BUB1 RIPOR1 ARAP1 TDRD1 THADA INSIG2 MORC3 USPL1 | 7.77e-05 | 197 | 254 | 10 | 6229_DN |
| Drug | Tranexamic acid [1197-18-8]; Up 200; 25.4uM; HL60; HG-U133A | 7.77e-05 | 197 | 254 | 10 | 1401_UP | |
| Drug | Mafenide hydrochloride [138-37-4]; Up 200; 18uM; HL60; HG-U133A | 7.77e-05 | 197 | 254 | 10 | 1441_UP | |
| Drug | Stachydrine hydrochloride; Up 200; 22.2uM; MCF7; HT_HG-U133A | 7.77e-05 | 197 | 254 | 10 | 2743_UP | |
| Drug | Terbutaline hemisulfate [23031-32-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A | HMCES GUF1 BRCA2 PVR NUP98 RBM12 TIAM1 CTNNBL1 SMARCC2 MORC3 | 7.77e-05 | 197 | 254 | 10 | 6240_DN |
| Drug | Imipenem [74431-23-5]; Up 200; 13.4uM; PC3; HT_HG-U133A | 8.10e-05 | 198 | 254 | 10 | 7294_UP | |
| Drug | 5253409; Down 200; 17uM; MCF7; HT_HG-U133A_EA | SYNJ2 VPS13A MTMR3 ETAA1 TACC1 ANKRD12 SASH1 PCNX4 INSIG2 MORC3 | 8.10e-05 | 198 | 254 | 10 | 961_DN |
| Drug | Trichlormethiazide [133-67-5]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 8.10e-05 | 198 | 254 | 10 | 3337_UP | |
| Drug | Butamben [94-25-7]; Down 200; 20.6uM; MCF7; HT_HG-U133A | 8.45e-05 | 199 | 254 | 10 | 6093_DN | |
| Drug | 5230742; Down 200; 17uM; MCF7; HT_HG-U133A_EA | 8.45e-05 | 199 | 254 | 10 | 862_DN | |
| Drug | Proxyphylline [603-00-9]; Up 200; 16.8uM; PC3; HT_HG-U133A | 8.45e-05 | 199 | 254 | 10 | 7290_UP | |
| Drug | Pentylenetetrazole [54-95-5]; Up 200; 29uM; PC3; HT_HG-U133A | 8.45e-05 | 199 | 254 | 10 | 2092_UP | |
| Drug | Letrozole [112809-51-5]; Down 200; 14uM; MCF7; HT_HG-U133A | 8.81e-05 | 200 | 254 | 10 | 7336_DN | |
| Drug | U cm | 8.97e-05 | 41 | 254 | 5 | CID000447446 | |
| Drug | 2,4-dichlorophenoxyacetic acid | 1.20e-04 | 132 | 254 | 8 | CID000001486 | |
| Disease | Prostatic Neoplasms | ASH1L BRCA2 PIK3R2 PVR NECTIN2 PLAU ASZ1 ICAM1 PCDH11Y AOX1 AHCYL2 ADAMTS8 TXNRD2 AR PKP3 INTS4 PRKDC ZMYM3 | 4.34e-06 | 616 | 244 | 18 | C0033578 |
| Disease | Malignant neoplasm of prostate | ASH1L BRCA2 PIK3R2 PVR NECTIN2 PLAU ASZ1 ICAM1 PCDH11Y AOX1 AHCYL2 ADAMTS8 TXNRD2 AR PKP3 INTS4 PRKDC ZMYM3 | 4.34e-06 | 616 | 244 | 18 | C0376358 |
| Disease | OROFACIAL CLEFT 1 | 6.81e-05 | 2 | 244 | 2 | C1861537 | |
| Disease | risk-taking behaviour | ZNF423 BIRC6 RYR2 KIRREL3 NRXN1 GLG1 ARID5B ANKRD52 SDK1 PLXNA2 CACNA1D PARP8 REST ASB3 USPL1 PCCA ICA1L EPHA5 | 7.45e-05 | 764 | 244 | 18 | EFO_0008579 |
| Disease | Myocardial Preinfarction Syndrome | 2.03e-04 | 3 | 244 | 2 | C0086666 | |
| Disease | Angina, Unstable | 2.03e-04 | 3 | 244 | 2 | C0002965 | |
| Disease | chronic obstructive pulmonary disease (implicated_via_orthology) | 2.03e-04 | 3 | 244 | 2 | DOID:3083 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of pancreas | 2.09e-04 | 102 | 244 | 6 | C0346647 | |
| Disease | emphysema imaging measurement | 2.22e-04 | 146 | 244 | 7 | EFO_0007626 | |
| Disease | QRS-T angle | 2.57e-04 | 106 | 244 | 6 | EFO_0020097 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 3.45e-04 | 157 | 244 | 7 | DOID:14330 (implicated_via_orthology) | |
| Disease | response to allogeneic hematopoietic stem cell transplant, donor genotype effect measurement, mortality | 6.70e-04 | 5 | 244 | 2 | EFO_0004352, EFO_0007044, EFO_0007892 | |
| Disease | non-syndromic X-linked intellectual disability (is_implicated_in) | 6.70e-04 | 5 | 244 | 2 | DOID:0050776 (is_implicated_in) | |
| Disease | psoriasis, coronary artery disease | 6.70e-04 | 5 | 244 | 2 | EFO_0000676, EFO_0001645 | |
| Disease | polybrominated biphenyl measurement, gestational serum measurement, polybrominated diphenyl ether measurement | 6.70e-04 | 5 | 244 | 2 | EFO_0007961, EFO_0007962, EFO_0007964 | |
| Disease | migraine disorder, Headache | 7.50e-04 | 86 | 244 | 5 | HP_0002315, MONDO_0005277 | |
| Disease | late-onset Alzheimers disease | 7.75e-04 | 292 | 244 | 9 | EFO_1001870 | |
| Disease | hypertension (is_marker_for) | 9.72e-04 | 53 | 244 | 4 | DOID:10763 (is_marker_for) | |
| Disease | Aicardi-Goutieres Syndrome 2 | 9.99e-04 | 6 | 244 | 2 | C3489724 | |
| Disease | carbamazepine metabolite measurement | 9.99e-04 | 6 | 244 | 2 | EFO_0009891 | |
| Disease | AICARDI-GOUTIERES SYNDROME 1 | 9.99e-04 | 6 | 244 | 2 | C0796126 | |
| Disease | Neurodevelopmental Disorders | 1.07e-03 | 93 | 244 | 5 | C1535926 | |
| Disease | reticulocyte count | GIPC2 INPP5D ASH1L TKTL1 BIRC6 FAT1 ERAL1 CNTN5 GLS VPS13A MTMR3 ANGPT1 REST AR THADA RANBP3L ASB3 DEPDC5 TRIM40 | 1.18e-03 | 1045 | 244 | 19 | EFO_0007986 |
| Disease | DNA methylation | DCHS2 TRIO ABCA13 ZNF423 NRXN1 PTPRS SLMAP TACC1 ADAMTSL1 SASH1 WDR27 IBTK THADA TIAM1 | 1.22e-03 | 656 | 244 | 14 | GO_0006306 |
| Disease | diet measurement | TRIO NUP210L KIRREL3 CNTN5 SCN2A NECTIN2 MTMR2 SDK1 ACSS3 MYO1H CARMIL1 PARP8 GRIK5 ALPK1 THADA CELSR2 DEPDC5 PRKDC PCCA | 1.24e-03 | 1049 | 244 | 19 | EFO_0008111 |
| Disease | chronic obstructive pulmonary disease (is_marker_for) | 1.29e-03 | 97 | 244 | 5 | DOID:3083 (is_marker_for) | |
| Disease | reticulocyte measurement | GIPC2 INPP5D ASH1L TKTL1 BIRC6 FAT1 ERAL1 CNTN5 GLS VPS13A MTMR3 ANGPT1 REST AR RANBP3L SBF2 ASB3 DEPDC5 TRIM40 | 1.29e-03 | 1053 | 244 | 19 | EFO_0010700 |
| Disease | Pseudo-TORCH syndrome | 1.39e-03 | 7 | 244 | 2 | C3489725 | |
| Disease | Adenoid Cystic Carcinoma | 1.48e-03 | 100 | 244 | 5 | C0010606 | |
| Disease | Pancreatic Neoplasm | 1.48e-03 | 100 | 244 | 5 | C0030297 | |
| Disease | neuroimaging measurement | DCHS2 NBL1 PLEKHH3 ZNF462 SLMAP MTMR2 PLXNA2 WWC1 ANGPT1 CARMIL1 SH2D5 KIF20B NR2F2 DENND4C THADA CBFA2T2 PAPPA PCCA ICA1L | 1.54e-03 | 1069 | 244 | 19 | EFO_0004346 |
| Disease | Subfertility, Female | 1.57e-03 | 28 | 244 | 3 | C0341869 | |
| Disease | Sterility, Postpartum | 1.57e-03 | 28 | 244 | 3 | C0038279 | |
| Disease | Female sterility | 1.57e-03 | 28 | 244 | 3 | C0917730 | |
| Disease | Female infertility | 1.57e-03 | 28 | 244 | 3 | C0021361 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.71e-03 | 152 | 244 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Mental Retardation, X-Linked | 1.74e-03 | 29 | 244 | 3 | C1136249 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 1.83e-03 | 105 | 244 | 5 | DOID:9352 (implicated_via_orthology) | |
| Disease | AICARDI-GOUTIERES SYNDROME | 1.85e-03 | 8 | 244 | 2 | C0393591 | |
| Disease | Fanconi anemia (implicated_via_orthology) | 1.85e-03 | 8 | 244 | 2 | DOID:13636 (implicated_via_orthology) | |
| Disease | vitamin D measurement | 2.04e-03 | 336 | 244 | 9 | EFO_0004631 | |
| Disease | Colorectal Carcinoma | CLSTN3 ABCA13 OBSCN WNK1 FAT1 SERPINB5 PTPRS BUB1 VPS13A ETAA1 ATP11C PARP8 TIAM1 SNRNP200 | 2.27e-03 | 702 | 244 | 14 | C0009402 |
| Disease | gastritis | 2.36e-03 | 9 | 244 | 2 | EFO_0000217 | |
| Disease | centronuclear myopathy X-linked (implicated_via_orthology) | 2.36e-03 | 9 | 244 | 2 | DOID:0111225 (implicated_via_orthology) | |
| Disease | Aicardi-Goutieres syndrome (is_implicated_in) | 2.36e-03 | 9 | 244 | 2 | DOID:0050629 (is_implicated_in) | |
| Disease | Graves Disease | 2.36e-03 | 9 | 244 | 2 | C0018213 | |
| Disease | non-syndromic X-linked intellectual disability (implicated_via_orthology) | 2.36e-03 | 9 | 244 | 2 | DOID:0050776 (implicated_via_orthology) | |
| Disease | Malignant tumor of prostate | 2.36e-03 | 9 | 244 | 2 | cv:C0376358 | |
| Disease | epilepsy (implicated_via_orthology) | 2.43e-03 | 163 | 244 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | asymmetrical dimethylarginine measurement, serum dimethylarginine measurement | 2.54e-03 | 33 | 244 | 3 | EFO_0005418, EFO_0006522 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | NHLRC1 ZNF423 BIRC6 RYR2 NRXN1 SCN2A HACE1 ARID5B SDK1 PLXNA2 ANO4 CACNA1D WDR27 REST PRKDC | 2.92e-03 | 801 | 244 | 15 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | Fanconi anemia (is_implicated_in) | 2.93e-03 | 10 | 244 | 2 | DOID:13636 (is_implicated_in) | |
| Disease | Alzheimer disease, gastroesophageal reflux disease | 3.00e-03 | 228 | 244 | 7 | EFO_0003948, MONDO_0004975 | |
| Disease | cardiac hypertrophy | 3.01e-03 | 35 | 244 | 3 | EFO_0002503 | |
| Disease | Leukemia, Myelocytic, Acute | 3.26e-03 | 173 | 244 | 6 | C0023467 | |
| Disease | response to serotonin-norephinephrine reuptake inhibitor | 3.26e-03 | 36 | 244 | 3 | EFO_0006325 | |
| Disease | age at first birth measurement | 3.27e-03 | 120 | 244 | 5 | EFO_0009101 | |
| Disease | chemotherapy-induced alopecia, response to antimicrotubule agent | 3.57e-03 | 11 | 244 | 2 | EFO_0005260, EFO_0005400 | |
| Disease | pars orbitalis volume measurement | 3.57e-03 | 11 | 244 | 2 | EFO_0010320 | |
| Disease | Cognitive impairment | 3.57e-03 | 11 | 244 | 2 | HP_0100543 | |
| Disease | Malignant neoplasm of breast | TPTE OBSCN WNK1 ADAR BMP1 SERPINB5 BRCA2 SYNJ2 NECTIN2 MTMR3 RCCD1 NUP98 TECTA AR PPP1R3A SIPA1L1 FCRL5 LRBA | 3.78e-03 | 1074 | 244 | 18 | C0006142 |
| Disease | Acute Myeloid Leukemia, M1 | 3.89e-03 | 125 | 244 | 5 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 3.89e-03 | 125 | 244 | 5 | C1879321 | |
| Disease | Intellectual Disability | SETD1A TRIO ASH1L ZNF462 NRXN1 CASP2 MED13L PPP2R1A SMARCC2 EIF3F | 4.29e-03 | 447 | 244 | 10 | C3714756 |
| Disease | physical activity measurement | 4.45e-03 | 245 | 244 | 7 | EFO_0008002 | |
| Disease | interleukin 6 receptor subunit alpha measurement | 5.00e-03 | 13 | 244 | 2 | EFO_0008187 | |
| Disease | renal sinus adipose tissue measurement | 5.00e-03 | 13 | 244 | 2 | EFO_0004864 | |
| Disease | retinol dehydrogenase 16 measurement | 5.00e-03 | 13 | 244 | 2 | EFO_0802007 | |
| Disease | Charcot-Marie-Tooth disease type 4 | 5.00e-03 | 13 | 244 | 2 | cv:C4082197 | |
| Disease | mean platelet volume | NHLRC1 NUP210L GLS PVR NECTIN2 RIPOR1 ARAP1 CARMIL1 SMURF1 REST CPNE5 MEIOC GCC2 INTS4 TRIM40 ESPL1 ICA1L | 5.10e-03 | 1020 | 244 | 17 | EFO_0004584 |
| Disease | age-related hearing impairment | 5.79e-03 | 324 | 244 | 8 | EFO_0005782 | |
| Disease | skin melanoma (is_implicated_in) | 5.80e-03 | 14 | 244 | 2 | DOID:8923 (is_implicated_in) | |
| Disease | pulse pressure measurement, social deprivation | 5.80e-03 | 14 | 244 | 2 | EFO_0005763, EFO_0009696 | |
| Disease | nephroblastoma (is_implicated_in) | 5.80e-03 | 14 | 244 | 2 | DOID:2154 (is_implicated_in) | |
| Disease | Fanconi anemia | 5.80e-03 | 14 | 244 | 2 | cv:C0015625 | |
| Disease | eating disorder, bipolar disorder | 5.80e-03 | 14 | 244 | 2 | EFO_0005203, MONDO_0004985 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 6.14e-03 | 45 | 244 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | ascending aortic diameter | 6.27e-03 | 140 | 244 | 5 | EFO_0021787 | |
| Disease | response to varenicline, Nausea | 6.66e-03 | 15 | 244 | 2 | EFO_0600052, HP_0002018 | |
| Disease | brain edema (biomarker_via_orthology) | 6.66e-03 | 15 | 244 | 2 | DOID:4724 (biomarker_via_orthology) | |
| Disease | Alzheimer disease, Cognitive impairment | 6.66e-03 | 15 | 244 | 2 | HP_0100543, MONDO_0004975 | |
| Disease | colorectal health | 6.71e-03 | 201 | 244 | 6 | EFO_0008460 | |
| Disease | non-high density lipoprotein cholesterol measurement | ZNF266 BRCA2 PLA2G12A PNLIPRP2 MYO1H CARMIL1 HEATR5A GRIK5 DENND4C THADA CELSR2 GCC2 INSIG2 | 6.74e-03 | 713 | 244 | 13 | EFO_0005689 |
| Disease | Celiac Disease | 6.93e-03 | 47 | 244 | 3 | C0007570 | |
| Disease | smoking status measurement | GIPC2 ZNF423 ADAR BIRC6 RYR2 NRXN1 CNTN5 SCN2A HACE1 ARID5B SDK1 PLXNA2 CACNA1D WDR27 GRIK5 REST PCCA ICA1L | 8.17e-03 | 1160 | 244 | 18 | EFO_0006527 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DISAVLGTKAAHGCV | 161 | O75410 | |
| HTVSVEKCSENGTVD | 1096 | Q9BXT4 | |
| NVLSEVCGQDITTKH | 506 | P30153 | |
| LKIVTIHECDSGEAS | 176 | Q8N350 | |
| CSIHLAEQSHEVESK | 206 | Q6UXE8 | |
| RSVGHSISIECKGID | 616 | Q9NR48 | |
| AVSASDKHCQVAESL | 686 | Q9NR48 | |
| KHCLSVETEADSGQA | 86 | Q86VW2 | |
| CRKTDDGQITEHAQS | 1336 | Q9NR09 | |
| QATIELQTSHVAKGC | 281 | Q9BQT9 | |
| AEIKEGCETHKVANT | 421 | O43683 | |
| VGTTEKEHEEHVCSI | 396 | Q8WYA6 | |
| CQEKISTTSIHGDRE | 561 | Q9NQI0 | |
| DQTGHKVLCSIIAGT | 591 | Q9UHX3 | |
| ESHNSITVSVCGRKA | 256 | Q4VNC1 | |
| DQKTSVCCVEDGVSH | 286 | Q9H981 | |
| SCSVIEDEGLQAAHT | 346 | Q9UP79 | |
| TGKSAVCIHQDINDD | 276 | Q5T8D3 | |
| VTEKGSVVLTCHTNN | 156 | Q3KPI0 | |
| LEVSGSCVNHSVTDE | 256 | P54756 | |
| AVVESHKLGGTCVNV | 91 | P00390 | |
| KTGVFRNQVDSETHC | 51 | Q9NRW3 | |
| RGSNTCEVHFENTKI | 266 | Q9H845 | |
| KEVREGCAAVLTSHS | 4901 | Q86UQ4 | |
| LAAEKHAGVSCVTAS | 41 | Q8WYK0 | |
| HAGVSCVTASVDDIQ | 46 | Q8WYK0 | |
| DSVKTICVGDHIESI | 151 | Q8TF65 | |
| VCVGDSIEAINDHSI | 151 | Q8TF64 | |
| DTVHNLVNLCTKEGV | 256 | Q15389 | |
| LVSDGVHSVTAQCAL | 1101 | Q9HCU4 | |
| DFCSQVHKIQTVSIG | 371 | Q96PN6 | |
| VTTLDHSQVSKEVCQ | 376 | Q32M45 | |
| HSQVSKEVCQATDII | 381 | Q32M45 | |
| ICEHTKQFQTISEES | 1316 | Q6UB98 | |
| TECVEVLTAHGASAL | 631 | Q8NB46 | |
| SIVCSVNHESLKGAD | 206 | Q8N126 | |
| EVKEVATLSCGHNVS | 41 | P33681 | |
| ATLSCGHNVSVEELA | 46 | P33681 | |
| LSVTGTVCHVGKAED | 81 | Q9BTZ2 | |
| HATECGGQVRADVKT | 856 | P13497 | |
| HGVQVICSIASTEKG | 266 | Q9BYV7 | |
| AQTICDVASRGHEQK | 1866 | Q2TAZ0 | |
| ITACSAHGSEEQILK | 116 | Q8WWH4 | |
| ETGTVHAASQLCKEA | 371 | Q96QP1 | |
| VEIDCLTGDHKNIRT | 1171 | Q06278 | |
| GESIVLNCKAIHDAS | 586 | O94779 | |
| EGDVNSAKVCAHITN | 536 | Q9NTZ6 | |
| CVGKTSLAHQFVEGE | 16 | Q8TAI7 | |
| DAVKASCGSRHTAVV | 301 | A6NED2 | |
| IDVSNGKVHVAESCL | 196 | O95825 | |
| CGLSDVAHVESLQEK | 326 | P24468 | |
| LVDVACKHLTDTSHG | 151 | Q96HW7 | |
| CTVDGQRHSTGDTKV | 266 | O94925 | |
| KDVTEAQIGDTLCLH | 326 | Q8N442 | |
| IASCLKEHVAAVAGE | 531 | P22736 | |
| CSQHIISVTGFVDSD | 706 | Q6ZW49 | |
| GEVAESAQKCTHLIA | 891 | Q6ZW49 | |
| ACVTATKRITEGEAH | 951 | O75140 | |
| SHKLVNLQCEETGVA | 666 | Q14517 | |
| HKIVLGIETSCDDTA | 36 | Q9H4B0 | |
| KTLGLTQHVQACETT | 141 | Q9BZM1 | |
| GETLNGKHQTDSIVC | 931 | Q13127 | |
| LSVTGTVCHVGKAED | 81 | Q6PKH6 | |
| CSGNDLEQLHIKVTS | 1711 | P52948 | |
| CEVITSSDLHKHGEI | 791 | Q8N3A8 | |
| ATTHFETTCDDIKNI | 406 | P50395 | |
| LHGESNVCTSVEIAQ | 171 | Q71F56 | |
| GCITTIHEDEVAKTQ | 496 | Q8IX03 | |
| EDENKIIGGHTCTRS | 36 | Q9P0G3 | |
| DGSVQVIKDHVTNCA | 811 | Q9NVR5 | |
| GVLCVLSADKNTTQH | 16 | Q04900 | |
| VCTESGVTQDHIKSL | 826 | Q86WG5 | |
| AAKDHTVVLTEDGCV | 236 | Q9P2D0 | |
| EGSVDSVFSQVCTHL | 176 | P00568 | |
| TQKVVYISCGEEHTA | 241 | Q15034 | |
| QHFSQGVEVKVSCSA | 616 | Q8NDA2 | |
| GQDVHAIVTRTCESV | 66 | Q8TAV5 | |
| NCKIETEHGTSILQS | 171 | Q8N0U4 | |
| EESKTSAQVFEHLIC | 16 | Q8N187 | |
| KCNTLFVVDVQSGHI | 116 | Q5VW00 | |
| VSCVEEDIQGHVTSV | 401 | Q8N6G6 | |
| STVTIEEFHCKLQEA | 151 | O43439 | |
| IKGLELQETSCHTAE | 681 | Q63HM2 | |
| LSHIGDAVVISCAKD | 151 | P12004 | |
| IHKGSITDACLSVVA | 1761 | O75051 | |
| ALNFEGTKVTLHCET | 296 | Q96RD9 | |
| GTKVTLHCETQEDSL | 301 | Q96RD9 | |
| CVEAEAKIHETQETT | 671 | Q14149 | |
| KETCHQSTETDAVFL | 741 | Q14149 | |
| VTKCTSGVDNAIDCH | 3176 | Q02505 | |
| HTTRCQALGVITEKE | 146 | O75616 | |
| IVAVSCGEAHTLALN | 86 | Q5GLZ8 | |
| HKTTVQCLLDSGADI | 176 | Q8IYU2 | |
| IVDLVSCGKEHSLAV | 76 | Q8IVU3 | |
| ESEGCVHILDSQTVV | 76 | Q96Q89 | |
| ETKLINDCHGSVSEA | 1221 | P50851 | |
| VESGKTSVVVHCSDG | 406 | Q13614 | |
| CVQTTLKDHTEGLSD | 66 | Q8IVH4 | |
| VCLTENTKGHLVVNS | 11 | Q8N8V2 | |
| DGKQLVEILTTHCDS | 51 | Q9NX02 | |
| QCEKHQDGLVVVTTK | 5481 | P98088 | |
| TTQKLTVSHIEGYEC | 656 | P10275 | |
| CLHVQLEETGDQKSS | 151 | P0C869 | |
| STLVEVAGTCVAHSE | 231 | Q5JZY3 | |
| EAKNITQIVGHSGCE | 36 | P41271 | |
| TQIVGHSGCEAKSIQ | 41 | P41271 | |
| HGVVAFKCENVATLD | 466 | Q9ULB1 | |
| TVKSVHCQAGDTVGE | 706 | P05165 | |
| CRTKVIDLSEGISQH | 1051 | Q13219 | |
| CVAVFVGINHASAKV | 111 | Q9Y5U4 | |
| HQVADGSVDVVVCTL | 131 | Q9H8H3 | |
| TPHKTVAAEECGSVV | 16 | Q9NY74 | |
| CIASNEAGEVSKHFI | 3506 | Q96RW7 | |
| ECVAQNSVGEITVHA | 106 | Q13332 | |
| ISGTCHELKAEDEVQ | 3356 | Q6V1P9 | |
| THDREKCGTGNITSV | 831 | Q16821 | |
| VCDAHDAQSSASVKV | 2236 | Q5VST9 | |
| ACSVVVDGDTKHCVI | 656 | O00459 | |
| VKTEGCSTEIHIQIG | 36 | Q13415 | |
| KDTVQIHDITGKDCQ | 166 | P02679 | |
| DSEISCHIQRETKGQ | 41 | A2A2Y4 | |
| HSQGEVVSCLEKGLV | 261 | Q92896 | |
| QEGHTKCVELLLSSG | 221 | Q9Y575 | |
| VVCDEGHILKNEASA | 1716 | P46100 | |
| CTEFGGVTQHLDSVK | 1061 | Q14674 | |
| SCQVTHEGSTVEKTV | 86 | P0CG04 | |
| TVHSGSTVELKCRAE | 1756 | Q6WRI0 | |
| SIGDTFSVHEAIDKC | 81 | Q86XA9 | |
| LKGETVNDCHAEIIS | 901 | P55265 | |
| SHTDCILAVKQAISG | 476 | P51587 | |
| SESGLEIHTVCSQKE | 536 | P51587 | |
| LGTVDKHSVEVTNCF | 121 | O00303 | |
| ETASATCPVVHKDGI | 1211 | Q05707 | |
| GIGFSTAECESQKHI | 2091 | O75417 | |
| SCQVTHEGSTVEKTV | 86 | P0DOY2 | |
| LESNGKDVFCTSHVL | 116 | Q9NQT6 | |
| SCQVTHEGSTVEKTV | 86 | P0DOY3 | |
| SCQVTHEGSTVEKTV | 86 | P0CF74 | |
| QVEEVSQTCSKSEIH | 881 | Q8IWJ2 | |
| SVLACSGEDIHVIEK | 911 | Q9BYX4 | |
| LLHCIKQTVTGGDSE | 216 | O75936 | |
| GHILKSTQDTCIGSE | 51 | A2RUB6 | |
| TEEVCDASAIVAKHS | 951 | Q5VZ89 | |
| HVQLVDVCTFSTAGK | 326 | Q49MI3 | |
| HTADTCQLEVALIGA | 211 | Q8WWB7 | |
| EGKSVEELSSTECHQ | 6 | P43080 | |
| ESCLELENHGTTDVK | 2291 | Q8TEP8 | |
| NTDCVQGLTHSKAQE | 46 | P13637 | |
| NEATVETLTETKIHC | 556 | Q9GZR7 | |
| HGQVLESEDCITKQI | 806 | Q2VIQ3 | |
| VLEDNVVTFHCSAKA | 261 | Q8IZU9 | |
| KCNTLFVVDVESGHI | 116 | Q5VU92 | |
| GCIAEIHNITSLDIS | 476 | Q5VZK9 | |
| ATTHFETTCNDIKDI | 406 | P31150 | |
| EVSEGTEVTVKCEAH | 321 | P05362 | |
| GVSNRCITTFEKAHD | 291 | Q05048 | |
| ASASTVSHICGEKEI | 101 | Q16478 | |
| SKLNAEVACVAVHDE | 46 | Q9UHL9 | |
| AKLEVFHSVQETCTE | 51 | Q8NDH6 | |
| TTAVISTCDHGIVAK | 351 | O60832 | |
| GLSQSEVKTDVCTVH | 531 | Q99590 | |
| EDHVVIKGTTATLHC | 581 | Q7Z5N4 | |
| TDDEVVLQCTATIHK | 16 | Q92736 | |
| VTDSCIVALLSHGVE | 266 | P42575 | |
| VSATKHEIADACDLT | 2081 | Q01668 | |
| NCEGSVKVSHLNLVD | 221 | Q02224 | |
| GTHCNQVEVIATLKD | 86 | P02775 | |
| TIITVDSCKGLSDIH | 196 | Q96FZ2 | |
| TITNDCHVVVTDAGD | 181 | Q6VVB1 | |
| SNEDGTFTICHKTEV | 206 | Q9HCH3 | |
| ALVTHICSGNEAEVD | 476 | Q9BXW9 | |
| SHTCAIDVDFNVGKI | 401 | P54317 | |
| EHLVQSVAKACASDS | 251 | Q13615 | |
| LGHTLVTVSVNECDK | 626 | Q5VU65 | |
| TVTDKDADHNGRVTC | 416 | Q9BZA8 | |
| CIEVGKNLIHGSDSV | 126 | Q13232 | |
| EICHDGKVVTIFSAS | 411 | O14829 | |
| VEVCHVVAVGAKSQS | 1001 | Q9Y2M0 | |
| SSQVDGKNVTCKVEH | 211 | P15151 | |
| KNVTDVVNTCHDAGI | 476 | Q9Y3I0 | |
| TVNCEDKVHESINSS | 926 | A2RUB1 | |
| NGAVREESIHCKSVE | 81 | Q8N983 | |
| DVVLLTAGEHNKACS | 436 | Q6PI48 | |
| VCLTQHVEKASASGV | 36 | Q6P9F5 | |
| CVLVVSDSKGSNELH | 11 | P00749 | |
| SDFQHELTDITVCTK | 1426 | Q6YHU6 | |
| KVSQEAIENGIHSAC | 621 | Q969S9 | |
| GAKIVGCTHITAQTA | 226 | Q96HN2 | |
| CAVAIDSHTTAGEVA | 416 | Q7Z736 | |
| KASVNIFHSGCVIVE | 131 | Q3ZLR7 | |
| FICSHLTAGQSQVKE | 681 | O15056 | |
| TELVCVTTHFKDLGN | 196 | O60921 | |
| TDHTCLNVNVTEVVK | 641 | Q5UE93 | |
| HSCLVESEGSLTENI | 281 | Q6ZV89 | |
| LSSHCTNAGVAVLEV | 451 | O43166 | |
| RISHICTDNVKTGIA | 501 | Q92835 | |
| SNVIHKVCLEITEDG | 316 | P36952 | |
| RVDHDTIIDATKCGN | 1626 | O15047 | |
| NKVSEHVGSRTQDEC | 621 | Q8TAQ2 | |
| VVDGSGQCHSTDTVK | 41 | Q9HCE7 | |
| EKAVQLAHSVEVCSF | 991 | Q9NRC6 | |
| CSDSAIVHQQIVGKD | 196 | Q499Z3 | |
| KASVNIFHSGCVIVE | 131 | P0C7V6 | |
| IEESILSHGTVADCA | 571 | Q9H6R3 | |
| CTVKVDQLGSDDIHN | 626 | Q14865 | |
| CISHVAAIGDQKFEV | 376 | Q96P48 | |
| ECVTTLEGHENEVKS | 96 | O76071 | |
| CFNEVKQSGAIIHTV | 421 | A8K7I4 | |
| SCIDEVKQSGAIVHF | 421 | Q14CN2 | |
| AVAACTKEIDTQGRH | 126 | Q5T681 | |
| CTSSIDGKHVDVVSD | 501 | Q8IYJ2 | |
| LCHTVEIKTNDAVDG | 471 | Q8NB49 | |
| LVTSINHALDAGKCE | 506 | Q9Y446 | |
| FAKVVVDGSGQCHST | 36 | Q9HAU4 | |
| SHDIIDAEVTCKAAQ | 1796 | O75443 | |
| ASILISNVCSIGDHV | 266 | Q9H4L4 | |
| TAAHCIQGTKEYSVV | 31 | Q7RTY3 | |
| KSCGHEVVSCLDVSE | 296 | Q9HCU5 | |
| ENDVQTVSHKCLVVG | 2911 | O15417 | |
| VHQSETTEVLCEGIK | 391 | Q8N1K5 | |
| VKVHSLSSEEGLCIT | 196 | Q8TCV5 | |
| ENIVAIHCKGGTDRT | 331 | P56180 | |
| VNEIKEDSHCGETFT | 91 | Q9H0M5 | |
| VHSEELKNTVTGLCS | 246 | Q5W0Q7 | |
| QKLQGHTDVVISAAC | 291 | Q86VZ2 | |
| KQDNTHVEAIACIGS | 346 | Q8TAM2 | |
| QFSIDTVGSHGAVKC | 2271 | Q96RL7 | |
| GTVVSSIHNVCTEAV | 1826 | Q8IZQ1 | |
| EANAVCEIVHVKSES | 1351 | Q13009 | |
| VQSVETVEGCTHEVA | 101 | P42285 | |
| NLAGEVSCKAELAVH | 1561 | Q15772 | |
| DALKLHECSVAAGVT | 441 | P98077 | |
| SVTKTVFHEEGICQD | 681 | Q9H5L6 | |
| LQLKENSESEGVSCH | 131 | Q9ULR3 | |
| TGEETEHNVLKINCK | 291 | Q86VV4 | |
| GVDVTENTRKVTHGC | 106 | Q14BN4 | |
| TITECGEDIRSQKSH | 196 | Q3SY52 | |
| SCISNHTTIEIGKDL | 1051 | Q99250 | |
| QLVELCGHASAVAVT | 91 | A6XGL0 | |
| SAKAHLDCDVSLGTV | 621 | Q9HCK1 | |
| SLSHTCLQEAGITEE | 1211 | O94885 | |
| SSENVIKCILHSTGN | 1376 | Q86WI1 | |
| CTAKGQVGSEQHSDI | 211 | Q9Y279 | |
| HGSCITEGNELTKTL | 1901 | P78527 | |
| GDHQLCKEEISATQI | 571 | O75643 | |
| LSSEEQICGTHRETK | 86 | A0A3B3IT33 | |
| NIKASFVDEHTVCGV | 156 | Q9NNW7 | |
| GYIVSTSCKHIIDDQ | 56 | Q71RH2 | |
| AGTEQKTEAVLHCEF | 2181 | Q96JM2 | |
| DTSVCGIATEHVEIE | 1781 | Q5VWN6 | |
| IQQAHCSVGSAKLES | 536 | Q2M1K9 | |
| LSLDDHVVAVCAGNK | 131 | A2RRH5 | |
| SNKGDRVVECQLETH | 1126 | Q9H4A3 | |
| VNEIKEDSHCGETFT | 71 | Q0D2J5 | |
| THCNVSTVNKGIQEI | 171 | Q9UN76 | |
| KGLANHVVVGSVSCE | 276 | Q6ZS17 | |
| HVVVGSVSCETKDLF | 281 | Q6ZS17 | |
| AHVCLINATATGTEI | 31 | Q13564 | |
| NSCSVLEAAKHQDIG | 281 | Q9UL49 | |
| KLQGHTDVVISTACH | 296 | P61964 | |
| QNTCSVITTLKGHEG | 186 | Q8IWB7 | |
| HCVSDKVTVIGAGIT | 471 | P51854 | |
| ICQKTGEVLHEVSNG | 411 | Q14202 | |
| SDKLSGGCELTVVIH | 1651 | O75962 | |
| VNEIKEDSHCGETFT | 86 | Q8NDP4 | |
| DTEFQGHKVILAACS | 41 | Q15916 | |
| EVSDVKQCGDVSSEH | 76 | Q14584 | |
| DAVLQCGHVFEAVTK | 961 | Q8N1T3 | |
| IHLDCSGKTSENAIV | 541 | Q14324 | |
| ADGVTVTCKVEHESF | 231 | Q92692 |